Generic placeholder image

当代肿瘤药物靶点

Editor-in-Chief

ISSN (Print): 1568-0096
ISSN (Online): 1873-5576

Review Article

抗肥胖药物在癌症治疗中的作用:一个全面的认识

卷 21, 期 6, 2021

发表于: 22 March, 2021

页: [476 - 494] 页: 19

弟呕挨: 10.2174/1568009621666210322122829

价格: $65

摘要

癌症和肥胖之间的相互作用是多因素和复杂的,肥胖个体癌症发展风险的增加构成了重大威胁。肥胖会导致癌细胞中多种致癌途径的上调或过度激活,从而导致癌细胞走向有害的表型。癌症和肥胖之间的交互作用被认为是化疗耐药和放疗耐药发展的一个重要因素。肥胖和癌症发展之间的联系是如此紧密,以至于一种对这两种情况都有效的药物将是必不可少的一步。在这种情况下,基于其化学预防潜力和化学治疗特性,抗肥胖药物提供了一份有价值的候选名单。目前的研究重点是探索抗肥胖药物作为双抗肿瘤药物的潜力。这些药物针对几个关键的信号通路(如AMPK, PI3K/Akt/mTOR, MAPK, NF-κB, JNK/ERK),这些通路被证明对癌症的生长和转移都至关重要。其中一些药物还在抑制引起癌症-肥胖交互作用的信号传导和细胞事件中发挥重要作用,并显示出对肿瘤转化的有效拮抗作用。因此,本综述强调了抗肥胖药物的潜在用途,以治疗癌症和肥胖患者的两种合并症。

关键词: 肥胖,癌症,抗肥胖药物,植物化学成分,信号通路,转移

图形摘要

[1]
Khan, N.; Afaq, F.; Mukhtar, H. Cancer chemoprevention through dietary antioxidants: progress and promise. Antioxidants & redox signaling., 2008, 10(3), 475-510..
[http://dx.doi.org/10.1089/ars.2007.1740]
[2]
Hanahan, D.; Weinberg, R.A. Hallmarks of cancer: the next generation. Cell, 2011, 144(5), 646-674.
[http://dx.doi.org/10.1016/j.cell.2011.02.013] [PMID: 21376230]
[3]
Ford, N.A.; Lashinger, L.M.; Allott, E.H.; Hursting, S.D. Mechanistic targets and phytochemical strategies for breaking the obesity-cancer link. Front. Oncol., 2013, 3, 209.
[http://dx.doi.org/10.3389/fonc.2013.00209] [PMID: 23967401]
[4]
Vogelstein, B.; Kinzler, K.W. Cancer genes and the pathways they control. Nat. Med., 2004, 10(8), 789-799.
[http://dx.doi.org/10.1038/nm1087] [PMID: 15286780]
[5]
De Pergola, G.; Silvestris, F. Obesity as a major risk factor for cancer. J. Obes., 2013, 2013, 291546.
[http://dx.doi.org/10.1155/2013/291546] [PMID: 24073332]
[6]
Azadbakht, L.; Jamali-Gojani, Z.; Heidari-Beni, M. Anti-obesity drug orlistat (xenical) is a novel antitumor medication. Shiraz E Med J, 2015, 16.
[http://dx.doi.org/10.17795/semj26242]
[7]
Gunter, M.J.; Hoover, D.R.; Yu, H.; Wassertheil-Smoller, S.; Rohan, T.E.; Manson, J.E.; Li, J.; Ho, G.Y.; Xue, X.; Anderson, G.L.; Kaplan, R.C.; Harris, T.G.; Howard, B.V.; Wylie-Rosett, J.; Burk, R.D.; Strickler, H.D. Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J. Natl. Cancer Inst., 2009, 101(1), 48-60.
[http://dx.doi.org/10.1093/jnci/djn415] [PMID: 19116382]
[8]
Ulanet, D.B.; Ludwig, D.L.; Kahn, C.R.; Hanahan, D. Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy. Proc. Natl. Acad. Sci. USA, 2010, 107(24), 10791-10798.
[http://dx.doi.org/10.1073/pnas.0914076107] [PMID: 20457905]
[9]
Bol, D.K.; Kiguchi, K.; Gimenez-Conti, I.; Rupp, T.; DiGiovanni, J. Overexpression of insulin-like growth factor-1 induces hyperplasia, dermal abnormalities, and spontaneous tumor formation in transgenic mice. Oncogene, 1997, 14(14), 1725-1734.
[http://dx.doi.org/10.1038/sj.onc.1201011] [PMID: 9135074]
[10]
Weigelt, B.; Peterse, J.L.; van ’t Veer, L.J. Breast cancer metastasis: markers and models. Nat. Rev. Cancer, 2005, 5(8), 591-602.
[http://dx.doi.org/10.1038/nrc1670] [PMID: 16056258]
[11]
Kalluri, R.; Weinberg, R.A. The basics of epithelial-mesenchymal transition. J. Clin. Invest., 2009, 119(6), 1420-1428.
[http://dx.doi.org/10.1172/JCI39104] [PMID: 19487818]
[12]
Nieman, K.M.; Kenny, H.A.; Penicka, C.V.; Ladanyi, A.; Buell-Gutbrod, R.; Zillhardt, M.R.; Romero, I.L.; Carey, M.S.; Mills, G.B.; Hotamisligil, G.S.; Yamada, S.D.; Peter, M.E.; Gwin, K.; Lengyel, E. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat. Med., 2011, 17(11), 1498-1503.
[http://dx.doi.org/10.1038/nm.2492] [PMID: 22037646]
[13]
Iyengar, N.M.; Hudis, C.A.; Dannenberg, A.J. Obesity and cancer: local and systemic mechanisms. Annu. Rev. Med., 2015, 66, 297-309.
[http://dx.doi.org/10.1146/annurev-med-050913-022228] [PMID: 25587653]
[14]
Lauby-Secretan, B.; Scoccianti, C.; Loomis, D.; Grosse, Y.; Bianchini, F.; Straif, K. International Agency for Research on Cancer Handbook Working Group. Body fatness and cancer--viewpoint of the IARC working group. N. Engl. J. Med., 2016, 375(8), 794-798.
[http://dx.doi.org/10.1056/NEJMsr1606602] [PMID: 27557308]
[15]
Alqahtani, S.; Qosa, H.; Primeaux, B.; Kaddoumi, A. Orlistat limits cholesterol intestinal absorption by Niemann-pick C1-like 1 (NPC1L1) inhibition. Eur. J. Pharmacol., 2015, 762, 263-269.
[http://dx.doi.org/10.1016/j.ejphar.2015.05.060] [PMID: 26048312]
[16]
Igel, L.I.; Kumar, R.B.; Saunders, K.H.; Aronne, L.J. Practical use of pharmacotherapy for obesity. Gastroenterology, 2017, 152(7), 1765-1779.
[http://dx.doi.org/10.1053/j.gastro.2016.12.049] [PMID: 28192104]
[17]
Narayanaswami, V.; Dwoskin, L.P. Obesity: Current and potential pharmacotherapeutics and targets. Pharmacol. Ther., 2017, 170, 116-147.
[http://dx.doi.org/10.1016/j.pharmthera.2016.10.015] [PMID: 27773782]
[18]
Redman, LM; Ravussin, E Lorcaserin for the treatment of obesity. Drugs of today (Barcelona, Spain : 1998)., 2010, 46(12), 901-910.
[http://dx.doi.org/10.1358/dot.2010.46.12.1556433]
[19]
Horn, H.; Böhme, B.; Dietrich, L.; Koch, M. Endocannabinoids in body weight control. Pharmaceuticals (Basel), 2018, 11(2), E55.
[http://dx.doi.org/10.3390/ph11020055] [PMID: 29849009]
[20]
Axel, A.M.; Mikkelsen, J.D.; Hansen, H.H. Tesofensine, a novel triple monoamine reuptake inhibitor, induces appetite suppression by indirect stimulation of alpha1 adrenoceptor and dopamine D1 receptor pathways in the diet-induced obese rat. Neuropsychopharmacology, 2010, 35(7), 1464-1476.
[http://dx.doi.org/10.1038/npp.2010.16] [PMID: 20200509]
[21]
Heck, A.M.; Yanovski, J.A.; Calis, K.A. Orlistat, a new lipase inhibitor for the management of obesity. Pharmacotherapy, 2000, 20(3), 270-279.
[http://dx.doi.org/10.1592/phco.20.4.270.34882] [PMID: 10730683]
[22]
Bryson, A.; de la Motte, S.; Dunk, C. Reduction of dietary fat absorption by the novel gastrointestinal lipase inhibitor cetilistat in healthy volunteers. Br. J. Clin. Pharmacol., 2009, 67(3), 309-315.
[http://dx.doi.org/10.1111/j.1365-2125.2008.03311.x] [PMID: 19220279]
[23]
Adams, J.M.; Pei, H.; Sandoval, D.A.; Seeley, R.J.; Chang, R.B.; Liberles, S.D.; Olson, D.P. Liraglutide modulates appetite and body weight through glucagon-like peptide 1 receptor-expressing glutamatergic neurons. Diabetes, 2018, 67(8), 1538-1548.
[http://dx.doi.org/10.2337/db17-1385] [PMID: 29776968]
[24]
Srivastava, G.; Apovian, C. Future pharmacotherapy for obesity: New anti-obesity drugs on the horizon. Curr. Obes. Rep., 2018, 7(2), 147-161.
[http://dx.doi.org/10.1007/s13679-018-0300-4] [PMID: 29504049]
[25]
Li, Z.; Liang, Y.; Xia, N.; Lai, Y.; Pan, H.; Zhou, S.; Jiang, F.; He, Y. Liraglutide reduces body weight by upregulation of adenylate cyclase 3. Nutr. Diabetes, 2017, 7(5), e265.
[http://dx.doi.org/10.1038/nutd.2017.17] [PMID: 28481334]
[26]
Malin, S.K.; Kashyap, S.R. Effects of metformin on weight loss: potential mechanisms. Curr. Opin. Endocrinol. Diabetes Obes., 2014, 21(5), 323-329.
[http://dx.doi.org/10.1097/MED.0000000000000095] [PMID: 25105996]
[27]
Mack, C.M.; Smith, P.A.; Athanacio, J.R.; Xu, K.; Wilson, J.K.; Reynolds, J.M.; Jodka, C.M.; Lu, M.G.; Parkes, D.G. Glucoregulatory effects and prolonged duration of action of davalintide: a novel amylinomimetic peptide. Diabetes Obes. Metab., 2011, 13(12), 1105-1113.
[http://dx.doi.org/10.1111/j.1463-1326.2011.01465.x] [PMID: 21733060]
[28]
Kim, G.W.; Lin, J.E.; Blomain, E.S.; Waldman, S.A. Antiobesity pharmacotherapy: new drugs and emerging targets. Clin. Pharmacol. Ther., 2014, 95(1), 53-66.
[http://dx.doi.org/10.1038/clpt.2013.204] [PMID: 24105257]
[29]
Padwal, R. Contrave, a bupropion and naltrexone combination therapy for the potential treatment of obesity. Curr. Opin. Investig. Drugs (London, England : 2000)., 2009, 10(10), 1117-1125.
[30]
Pan, M.H.; Wu, J.C.; Ho, C.T.; Lai, C.S. Antiobesity molecular mechanisms of action: Resveratrol and pterostilbene. Biofactors, 2018, 44(1), 50-60.
[http://dx.doi.org/10.1002/biof.1409] [PMID: 29315906]
[31]
Chatterjee, C.; Gleddie, S.; Xiao, C.W. Soybean bioactive peptides and their functional properties. Nutrients, 2018, 10(9), E1211.
[http://dx.doi.org/10.3390/nu10091211] [PMID: 30200502]
[32]
Chen, S.; Jiang, H.; Wu, X.; Fang, J. Therapeutic effects of quercetin on inflammation, obesity, and type 2 diabetes. Mediators Inflamm., 2016, 2016, 9340637.
[http://dx.doi.org/10.1155/2016/9340637] [PMID: 28003714]
[33]
Sharma, K.; Kang, S.; Gong, D.; Oh, S.H.; Park, E.Y.; Oak, M.H.; Yi, E. Combination of Garcinia cambogia extract and pear pomace extract additively suppresses adipogenesis and enhances lipolysis in 3T3-L1 Cells. Pharmacogn. Mag., 2018, 14(54), 220-226.
[http://dx.doi.org/10.4103/pm.pm_388_17] [PMID: 29720835]
[34]
Mashmoul, M.; Azlan, A.; Khaza’ai, H.; Yusof, B.N.; Noor, S.M. Saffron: A natural potent antioxidant as a promising anti-obesity drug. Antioxidants, 2013, 2(4), 293-308.
[http://dx.doi.org/10.3390/antiox2040293] [PMID: 26784466]
[35]
Islam, M.T.; Ali, E.S.; Mubarak, M.S. Anti-obesity effect of plant diterpenes and their derivatives: A review. Phytother. Res., 2020, 34(6), 1216-1225.
[http://dx.doi.org/10.1002/ptr.6602] [PMID: 31977122]
[36]
Liu, M.; Xu, L.; Yin, L.; Qi, Y.; Xu, Y.; Han, X.; Zhao, Y.; Sun, H.; Yao, J.; Lin, Y.; Liu, K.; Peng, J. Potent effects of dioscin against obesity in mice. Sci. Rep., 2015, 5, 7973.
[http://dx.doi.org/10.1038/srep07973] [PMID: 25609476]
[37]
Katashima, C.K.; Silva, V.R.; Gomes, T.L.; Pichard, C.; Pimentel, G.D. Ursolic acid and mechanisms of actions on adipose and muscle tissue: a systematic review. Obes. Rev., 2017, 18(6), 700-711.
[http://dx.doi.org/10.1111/obr.12523] [PMID: 28335087]
[38]
Lee, H.E.; Yang, G.; Han, S.H.; Lee, J.H.; An, T.J.; Jang, J.K.; Lee, J.Y. Anti-obesity potential of Glycyrrhiza uralensis and licochalcone A through induction of adipocyte browning. Biochem. Biophys. Res. Commun., 2018, 503(3), 2117-2123.
[http://dx.doi.org/10.1016/j.bbrc.2018.07.168] [PMID: 30093114]
[39]
Zhang, Z.; Zhang, H.; Li, B.; Meng, X.; Wang, J.; Zhang, Y.; Yao, S.; Ma, Q.; Jin, L.; Yang, J.; Wang, W.; Ning, G. Berberine activates thermogenesis in white and brown adipose tissue. Nat. Commun., 2014, 5, 5493.
[http://dx.doi.org/10.1038/ncomms6493] [PMID: 25423280]
[40]
Kim, H.L.; Park, J.; Jung, Y.; Ahn, K.S.; Um, J.Y. Platycodin D, a novel activator of AMP-activated protein kinase, attenuates obesity in db/db mice via regulation of adipogenesis and thermogenesis. Phytomedicine, 2019, 52, 254-263.
[41]
Zheng, J.; Zheng, S.; Feng, Q.; Zhang, Q.; Xiao, X. Dietary capsaicin and its anti-obesity potency: from mechanism to clinical implications. Biosci. Rep., 2017, 37(3), BSR20170286.
[http://dx.doi.org/10.1042/BSR20170286] [PMID: 28424369]
[42]
Wang, J.; Zhang, L.; Dong, L.; Hu, X.; Feng, F.; Chen, F. 6-gingerol, a functional polyphenol of ginger, promotes browning through an AMPK-dependent pathway in 3T3-L1 adipocytes. J. Agric. Food Chem., 2019, 67(51), 14056-14065.
[http://dx.doi.org/10.1021/acs.jafc.9b05072] [PMID: 31789021]
[43]
Liu, J.; Lee, J.; Salazar Hernandez, M.A.; Mazitschek, R.; Ozcan, U. Treatment of obesity with celastrol. Cell, 2015, 161(5), 999-1011.
[http://dx.doi.org/10.1016/j.cell.2015.05.011] [PMID: 26000480]
[44]
Di Fabio, G.; Romanucci, V.; Zarrelli, M.; Giordano, M.; Zarrelli, A. C-4 gem-dimethylated oleanes of Gymnema sylvestre and their pharmacological activities. Molecules, 2013, 18(12), 14892-14919.
[http://dx.doi.org/10.3390/molecules181214892] [PMID: 24304585]
[45]
Albracht-Schulte, K.; Kalupahana, N.S.; Ramalingam, L.; Wang, S.; Rahman, S.M.; Robert-McComb, J.; Moustaid-Moussa, N. Omega-3 fatty acids in obesity and metabolic syndrome: a mechanistic update. J. Nutr. Biochem., 2018, 58, 1-16.
[http://dx.doi.org/10.1016/j.jnutbio.2018.02.012] [PMID: 29621669]
[46]
Polus, A.; Zapala, B.; Razny, U.; Gielicz, A.; Kiec-Wilk, B.; Malczewska-Malec, M.; Sanak, M.; Childs, C.E.; Calder, P.C.; Dembinska-Kiec, A. Omega-3 fatty acid supplementation influences the whole blood transcriptome in women with obesity, associated with pro-resolving lipid mediator production. Biochim. Biophys. Acta, 2016, 1861(11), 1746-1755.
[http://dx.doi.org/10.1016/j.bbalip.2016.08.005] [PMID: 27531277]
[47]
Huang, F.; Del-Río-Navarro, B.E.; Leija-Martinez, J.; Torres-Alcantara, S.; Ruiz-Bedolla, E.; Hernández-Cadena, L.; Barraza-Villarreal, A.; Romero-Nava, R.; Sanchéz-Muñoz, F.; Villafaña, S.; Marchat, L.A.; Hong, E. Effect of omega-3 fatty acids supplementation combined with lifestyle intervention on adipokines and biomarkers of endothelial dysfunction in obese adolescents with hypertriglyceridemia. J. Nutr. Biochem., 2019, 64, 162-169.
[http://dx.doi.org/10.1016/j.jnutbio.2018.10.012] [PMID: 30513433]
[48]
Schcolnik-Cabrera, A.; Chávez-Blanco, A.; Domínguez-Gómez, G.; Taja-Chayeb, L.; Morales-Barcenas, R.; Trejo-Becerril, C.; Perez-Cardenas, E.; Gonzalez-Fierro, A.; Dueñas-González, A. Orlistat as a FASN inhibitor and multitargeted agent for cancer therapy. Expert Opin. Investig. Drugs, 2018, 27(5), 475-489.
[http://dx.doi.org/10.1080/13543784.2018.1471132] [PMID: 29723075]
[49]
Zhao, W.; Zhang, X.; Zhou, Z.; Sun, B.; Gu, W.; Liu, J.; Zhang, H. Liraglutide inhibits the proliferation and promotes the apoptosis of MCF-7 human breast cancer cells through downregulation of microRNA-27a expression. Mol. Med. Rep., 2018, 17(4), 5202-5212.
[http://dx.doi.org/10.3892/mmr.2018.8475] [PMID: 29393459]
[50]
Krause, G.C.; Lima, K.G.; Dias, H.B.; da Silva, E.F.G.; Haute, G.V.; Basso, B.S.; Gassen, R.B.; Marczak, E.S.; Nunes, R.S.B.; de Oliveira, J.R. Liraglutide, a glucagon-like peptide-1 analog, induce autophagy and senescence in HepG2 cells. Eur. J. Pharmacol., 2017, 809, 32-41.
[http://dx.doi.org/10.1016/j.ejphar.2017.05.015] [PMID: 28501576]
[51]
Lei, Y.; Yi, Y.; Liu, Y.; Liu, X.; Keller, E.T.; Qian, C.N.; Zhang, J.; Lu, Y. Metformin targets multiple signaling pathways in cancer. Chin. J. Cancer, 2017, 36(1), 17.
[http://dx.doi.org/10.1186/s40880-017-0184-9] [PMID: 28126011]
[52]
Saini, N.; Yang, X. Metformin as an anti-cancer agent: actions and mechanisms targeting cancer stem cells. Acta Biochim. Biophys. Sin. (Shanghai), 2018, 50(2), 133-143.
[http://dx.doi.org/10.1093/abbs/gmx106] [PMID: 29342230]
[53]
Sharma, A.; Bandyopadhayaya, S.; Chowdhury, K.; Sharma, T.; Maheshwari, R.; Das, A.; Chakrabarti, G.; Kumar, V.; Mandal, C.C. Metformin exhibited anticancer activity by lowering cellular cholesterol content in breast cancer cells. PLoS One, 2019, 14(1), e0209435.
[http://dx.doi.org/10.1371/journal.pone.0209435] [PMID: 30625181]
[54]
Proto, M.C.; Fiore, D.; Piscopo, C.; Franceschelli, S.; Bizzarro, V.; Laezza, C.; Lauro, G.; Feoli, A.; Tosco, A.; Bifulco, G.; Sbardella, G.; Bifulco, M.; Gazzerro, P. Inhibition of Wnt/β- Catenin pathway and Histone acetyltransferase activity by Rimonabant: a therapeutic target for colon cancer. Sci. Rep., 2017, 7(1), 11678.
[http://dx.doi.org/10.1038/s41598-017-11688-x] [PMID: 28916833]
[55]
Svacina, S. Treatment of an obese diabetic. Vnitr. Lek., 2010, 56(10), 1078-1081.
[PMID: 21105456]
[56]
Braga, T.; Kraemer-Aguiar, L.G.; Docherty, N.G.; Le Roux, C.W. Treating prediabetes: why and how should we do it? Minerva Med., 2019, 110(1), 52-61.
[http://dx.doi.org/10.23736/S0026-4806.18.05897-4] [PMID: 30371047]
[57]
Saleem, F.; Rizvi, S.W. New Therapeutic approaches in obesity and metabolic syndrome associated with polycystic ovary syndrome. Cureus, 2017, 9(11), e1844.
[http://dx.doi.org/10.7759/cureus.1844] [PMID: 29344438]
[58]
Rodgers, R.J.; Tschöp, M.H.; Wilding, J.P. Anti-obesity drugs: past, present and future. Dis. Model. Mech., 2012, 5(5), 621-626.
[http://dx.doi.org/10.1242/dmm.009621] [PMID: 22915024]
[59]
Hsiao, Y.H.; Chen, N.C.; Koh, Y.C.; Nagabhushanam, K.; Ho, C.T.; Pan, M.H. Pterostilbene inhibits adipocyte conditioned-medium-induced colorectal cancer cell migration through targeting FABP5-related signaling pathway. J. Agric. Food Chem., 2019, 67(37), 10321-10329.
[http://dx.doi.org/10.1021/acs.jafc.9b03997] [PMID: 31419115]
[60]
Kim, K.; Shin, E.A.; Jung, J.H.; Park, J.E.; Kim, D.S.; Shim, B.S.; Kim, S.H. Ursolic acid induces apoptosis in colorectal cancer cells partially via upregulation of MicroRNA-4500 and inhibition of JAK2/STAT3 phosphorylation. Int. J. Mol. Sci., 2018, 20(1), E114.
[http://dx.doi.org/10.3390/ijms20010114] [PMID: 30597956]
[61]
Lucas, J.; Hsieh, T.C.; Halicka, H.D.; Darzynkiewicz, Z.; Wu, J.M. Upregulation of PD‑L1 expression by resveratrol and piceatannol in breast and colorectal cancer cells occurs via HDAC3/p300‑mediated NF‑κB signaling. Int. J. Oncol., 2018, 53(4), 1469-1480.
[http://dx.doi.org/10.3892/ijo.2018.4512] [PMID: 30066852]
[62]
Bufu, T.; Di, X.; Yilin, Z.; Gege, L.; Xi, C.; Ling, W. Celastrol inhibits colorectal cancer cell proliferation and migration through suppression of MMP3 and MMP7 by the PI3K/AKT signaling pathway. Anticancer Drugs, 2018, 29(6), 530-538.
[http://dx.doi.org/10.1097/CAD.0000000000000621] [PMID: 29553945]
[63]
Xu, S.; Zhang, L.; Cheng, X.; Yu, H.; Bao, J.; Lu, R. Capsaicin inhibits the metastasis of human papillary thyroid carcinoma BCPAP cells through the modulation of the TRPV1 channel. Food Funct., 2018, 9(1), 344-354.
[http://dx.doi.org/10.1039/C7FO01295K] [PMID: 29185571]
[64]
Xue, L.; Zhang, W.J.; Fan, Q.X.; Wang, L.X. Licochalcone A inhibits PI3K/Akt/mTOR signaling pathway activation and promotes autophagy in breast cancer cells. Oncol. Lett., 2018, 15(2), 1869-1873.
[PMID: 29399197]
[65]
Hsieh, C.C.; Wang, C.H.; Huang, Y.S. Lunasin attenuates obesity-associated metastasis of 4T1 breast cancer cell through anti-inflammatory property. Int. J. Mol. Sci., 2016, 17(12), E2109.
[http://dx.doi.org/10.3390/ijms17122109] [PMID: 27983683]
[66]
Ward, A.B.; Mir, H.; Kapur, N.; Gales, D.N.; Carriere, P.P.; Singh, S. Quercetin inhibits prostate cancer by attenuating cell survival and inhibiting anti-apoptotic pathways. World J. Surg. Oncol., 2018, 16(1), 108.
[http://dx.doi.org/10.1186/s12957-018-1400-z] [PMID: 29898731]
[67]
Lim, W.C.; Kim, H.; Kim, Y.J.; Choi, K.C.; Lee, I.H.; Lee, K.H.; Kim, M.K.; Ko, H. Dioscin suppresses TGF-β1-induced epithelial-mesenchymal transition and suppresses A549 lung cancer migration and invasion. Bioorg. Med. Chem. Lett., 2017, 27(15), 3342-3348.
[http://dx.doi.org/10.1016/j.bmcl.2017.06.014] [PMID: 28610976]
[68]
Khan, M.; Maryam, A.; Zhang, H.; Mehmood, T.; Ma, T. Killing cancer with platycodin D through multiple mechanisms. J. Cell. Mol. Med., 2016, 20(3), 389-402.
[http://dx.doi.org/10.1111/jcmm.12749] [PMID: 26648178]
[69]
Colapietro, A.; Mancini, A.; D’Alessandro, A.M.; Festuccia, C. Crocetin and crocin from saffron in cancer chemotherapy and chemoprevention. Anticancer. Agents Med. Chem., 2019, 19(1), 38-47.
[http://dx.doi.org/10.2174/1871520619666181231112453] [PMID: 30599111]
[70]
Chakraborty, D.; Ghosh, S.; Bishayee, K.; Mukherjee, A.; Sikdar, S.; Khuda-Bukhsh, A.R. Antihyperglycemic drug gymnema sylvestre also shows anticancer potentials in human melanoma A375 cells via reactive oxygen species generation and mitochondria-dependent caspase pathway. Integr. Cancer Ther., 2013, 12(5), 433-441.
[http://dx.doi.org/10.1177/1534735413485419] [PMID: 23615751]
[71]
Wang, J.; Xu, J.; Peng, Y.; Xiao, Y.; Zhu, H.; Ding, Z.M.; Hua, H. Phosphorylation of extracellular signal-regulated kinase as a biomarker for cannabinoid receptor 2 activation. Heliyon, 2018, 4(11), e00909.
[http://dx.doi.org/10.1016/j.heliyon.2018.e00909] [PMID: 30450437]
[72]
Luo, Y.; Chen, X.; Luo, L.; Zhang, Q.; Gao, C.; Zhuang, X.; Yuan, S.; Qiao, T. [6]-Gingerol enhances the radiosensitivity of gastric cancer via G2/M phase arrest and apoptosis induction. Oncol. Rep., 2018, 39(5), 2252-2260.
[http://dx.doi.org/10.3892/or.2018.6292] [PMID: 29512739]
[73]
Sharma, T.; Mandal, C.C. Omega-3 fatty acids in pathological calcification and bone health. J. Food Biochem., 2020, 44(8), e13333.
[http://dx.doi.org/10.1111/jfbc.13333] [PMID: 32548903]
[74]
Sharma, T.; Sharma, A.; Maheshwari, R.; Pachori, G.; Kumari, P.; Mandal, C.C. Docosahexaenoic acid (DHA) inhibits bone morphogenetic protein-2 (BMP-2) elevated osteoblast potential of metastatic breast cancer (MDA-MB-231) cells in mammary microcalcification. Nutr. Cancer, 2020, 72(5), 873-883.
[http://dx.doi.org/10.1080/01635581.2019.1651879] [PMID: 31409173]
[75]
Mandal, C.C.; Ghosh-Choudhury, T.; Dey, N.; Choudhury, G.G.; Ghosh-Choudhury, N. miR-21 is targeted by omega-3 polyunsaturated fatty acid to regulate breast tumor CSF-1 expression. Carcinogenesis, 2012, 33(10), 1897-1908.
[http://dx.doi.org/10.1093/carcin/bgs198] [PMID: 22678116]
[76]
Mandal, C.C.; Ghosh-Choudhury, T.; Yoneda, T.; Choudhury, G.G.; Ghosh-Choudhury, N. Fish oil prevents breast cancer cell metastasis to bone. Biochem. Biophys. Res. Commun., 2010, 402(4), 602-607.
[http://dx.doi.org/10.1016/j.bbrc.2010.10.063] [PMID: 20971068]
[77]
Ghosh-Choudhury, T.; Mandal, C.C.; Woodruff, K.; St Clair, P.; Fernandes, G.; Choudhury, G.G.; Ghosh-Choudhury, N. Fish oil targets PTEN to regulate NFkappaB for downregulation of anti-apoptotic genes in breast tumor growth. Breast Cancer Res. Treat., 2009, 118(1), 213-228.
[http://dx.doi.org/10.1007/s10549-008-0227-7] [PMID: 18953692]
[78]
Gu, Z.; Shan, K.; Chen, H.; Chen, Y.Q. n-3 Polyunsaturated fatty acids and their role in cancer chemoprevention. Curr. Pharmacol. Rep., 2015, 1(5), 283-294.
[http://dx.doi.org/10.1007/s40495-015-0043-9] [PMID: 26457243]
[79]
Serini, S.; Ottes Vasconcelos, R.; Fasano, E.; Calviello, G. How plausible is the use of dietary n-3 PUFA in the adjuvant therapy of cancer? Nutr. Res. Rev., 2016, 29(1), 102-125.
[http://dx.doi.org/10.1017/S0954422416000044] [PMID: 27172872]
[80]
Li, Y.R.; Li, S.; Lin, C.C. Effect of resveratrol and pterostilbene on aging and longevity. Biofactors, 2018, 44(1), 69-82.
[http://dx.doi.org/10.1002/biof.1400] [PMID: 29210129]
[81]
Srinivasan, K. Antioxidant potential of spices and their active constituents. Crit. Rev. Food Sci. Nutr., 2014, 54(3), 352-372.
[http://dx.doi.org/10.1080/10408398.2011.585525] [PMID: 24188307]
[82]
Kant, S.; Kumar, A.; Singh, S.M. Fatty acid synthase inhibitor orlistat induces apoptosis in T cell lymphoma: role of cell survival regulatory molecules. Biochim. Biophys. Acta, 2012, 1820(11), 1764-1773.
[http://dx.doi.org/10.1016/j.bbagen.2012.07.010] [PMID: 22877747]
[83]
Menendez, J.A.; Vellon, L.; Lupu, R. The antiobesity drug Orlistat induces cytotoxic effects, suppresses Her-2/neu (erbB-2) oncogene overexpression, and synergistically interacts with trastuzumab (Herceptin) in chemoresistant ovarian cancer cells. Int J Gynecol Cancer, 2006, 16(1), 219-221.
[84]
Fujiwara, J.; Sowa, Y.; Horinaka, M.; Koyama, M.; Wakada, M.; Miki, T.; Sakai, T. The anti-obesity drug orlistat promotes sensitivity to TRAIL by two different pathways in hormone-refractory prostate cancer cells. Int. J. Oncol., 2016, 48(2), 854.
[PMID: 26648205]
[85]
Tang, W.; Zhu, J.; Su, S.; Wu, W.; Liu, Q.; Su, F.; Yu, F. MiR-27 as a prognostic marker for breast cancer progression and patient survival. PLoS One, 2012, 7(12), e51702.
[http://dx.doi.org/10.1371/journal.pone.0051702] [PMID: 23240057]
[86]
Fox, M.M.; Phoenix, K.N.; Kopsiaftis, S.G.; Claffey, K.P. AMP-activated protein kinase α 2 isoform suppression in primary breast cancer alters AMPK growth control and apoptotic signaling. Genes Cancer, 2013, 4(1-2), 3-14.
[http://dx.doi.org/10.1177/1947601913486346] [PMID: 23946867]
[87]
Podhorecka, M.; Ibanez, B.; Dmoszyńska, A. Metformin - its potential anti-cancer and anti-aging effects. Postepy Hig. Med. Dosw., 2017, 71(0), 170-175.
[http://dx.doi.org/10.5604/01.3001.0010.3801] [PMID: 28258677]
[88]
Ben Sahra, I.; Regazzetti, C.; Robert, G.; Laurent, K.; Le Marchand-Brustel, Y.; Auberger, P.; Tanti, J.F.; Giorgetti-Peraldi, S.; Bost, F. Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1. Cancer Res., 2011, 71(13), 4366-4372.
[http://dx.doi.org/10.1158/0008-5472.CAN-10-1769] [PMID: 21540236]
[89]
Shi, W.Y.; Xiao, D.; Wang, L.; Dong, L.H.; Yan, Z.X.; Shen, Z.X.; Chen, S.J.; Chen, Y.; Zhao, W.L. Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy. Cell Death Dis., 2012, 3(3), e275.
[http://dx.doi.org/10.1038/cddis.2012.13] [PMID: 22378068]
[90]
Karnevi, E.; Said, K.; Andersson, R.; Rosendahl, A.H. Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells. BMC Cancer, 2013, 13, 235.
[http://dx.doi.org/10.1186/1471-2407-13-235] [PMID: 23663483]
[91]
Panka, DJ; Atkins, MB; Mier, JW Targeting the mitogen-activated protein kinase pathway in the treatment of malignant melanoma. Clin Cancer Res, 2006, 17(Pt 2), 2371s-2375s.
[http://dx.doi.org/10.1158/1078-0432.CCR-05-2539]
[92]
Hirsch, H.A.; Iliopoulos, D.; Tsichlis, P.N.; Struhl, K. Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. Cancer Res., 2009, 69(19), 7507-7511.
[http://dx.doi.org/10.1158/0008-5472.CAN-09-2994] [PMID: 19752085]
[93]
Castellone, M.D.; Teramoto, H.; Williams, B.O.; Druey, K.M.; Gutkind, J.S. Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science, 2005, 310(5753), 1504-1510.
[http://dx.doi.org/10.1126/science.1116221] [PMID: 16293724]
[94]
Kannan-Thulasiraman, P.; Seachrist, D.D.; Mahabeleshwar, G.H.; Jain, M.K.; Noy, N. Fatty acid-binding protein 5 and PPARbeta/delta are critical mediators of epidermal growth factor receptor-induced carcinoma cell growth. J. Biol. Chem., 2010, 285(25), 19106-19115.
[http://dx.doi.org/10.1074/jbc.M109.099770] [PMID: 20424164]
[95]
Chen Lf, ; Fischle, W.; Verdin, E.; Greene, W.C. Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science, 2001, 293(5535), 1653-1657.
[http://dx.doi.org/10.1126/science.1062374] [PMID: 11533489]
[96]
Barton, B.E.; Karras, J.G.; Murphy, T.F.; Barton, A.; Huang, H.F. Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: Direct STAT3 inhibition induces apoptosis in prostate cancer lines. Mol. Cancer Ther., 2004, 3(1), 11-20.
[http://dx.doi.org/10.1186/1476-4598-3-11] [PMID: 14749471]
[97]
Ahmed, F.E. Role of miRNA in carcinogenesis and biomarker selection: a methodological view. Expert Rev. Mol. Diagn., 2007, 7(5), 569-603.
[http://dx.doi.org/10.1586/14737159.7.5.569] [PMID: 17892365]
[98]
Yu, F.Y.; Tu, Y.; Deng, Y.; Guo, C.; Ning, J.; Zhu, Y.; Lv, X.; Ye, H. MiR-4500 is epigenetically downregulated in colorectal cancer and functions as a novel tumor suppressor by regulating HMGA2. Cancer Biol. Ther., 2016, 17(11), 1149-1157.
[http://dx.doi.org/10.1080/15384047.2016.1235661] [PMID: 27686621]
[99]
Agarwal, E.; Brattain, M.G.; Chowdhury, S. Cell survival and metastasis regulation by Akt signaling in colorectal cancer. Cell. Signal., 2013, 25(8), 1711-1719.
[http://dx.doi.org/10.1016/j.cellsig.2013.03.025] [PMID: 23603750]
[100]
Zucker, S.; Vacirca, J. Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev., 2004, 23(1-2), 101-117.
[http://dx.doi.org/10.1023/A:1025867130437] [PMID: 15000152]
[101]
Litan, A.; Langhans, S.A. Cancer as a channelopathy: ion channels and pumps in tumor development and progression. Front. Cell. Neurosci., 2015, 9, 86.
[http://dx.doi.org/10.3389/fncel.2015.00086] [PMID: 25852478]
[102]
Lee, H.J.; Li, C.F.; Ruan, D.; Powers, S.; Thompson, P.A.; Frohman, M.A.; Chan, C.H. The DNA damage transducer RNF8 facilitates Cancer chemoresistance and progression through twist activation. Mol. Cell, 2016, 63(6), 1021-1033.
[http://dx.doi.org/10.1016/j.molcel.2016.08.009] [PMID: 27618486]
[103]
Lamparska-Przybysz, M.; Gajkowska, B.; Motyl, T. BID-deficient breast cancer MCF-7 cells as a model for the study of autophagy in cancer therapy. Autophagy, 2006, 2(1), 47-48.
[http://dx.doi.org/10.4161/auto.2149] [PMID: 16874058]
[104]
Pan, S.T.; Qin, Y.; Zhou, Z.W.; He, Z.X.; Zhang, X.; Yang, T.; Yang, Y.X.; Wang, D.; Qiu, J.X.; Zhou, S.F. Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells. Drug Des. Devel. Ther., 2015, 9, 1601-1626.
[PMID: 25834400]
[105]
Tsai, J.P.; Lee, C.H.; Ying, T.H.; Lin, C.L.; Lin, C.L.; Hsueh, J.T.; Hsieh, Y.H. Licochalcone A induces autophagy through PI3K/Akt/mTOR inactivation and autophagy suppression enhances Licochalcone A-induced apoptosis of human cervical cancer cells. Oncotarget, 2015, 6(30), 28851-28866.
[http://dx.doi.org/10.18632/oncotarget.4767] [PMID: 26311737]
[106]
Allavena, P.; Mantovani, A. Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment. Clin. Exp. Immunol., 2012, 167(2), 195-205.
[http://dx.doi.org/10.1111/j.1365-2249.2011.04515.x] [PMID: 22235995]
[107]
Fan, F.; Schimming, A.; Jaeger, D.; Podar, K. Targeting the tumor microenvironment: focus on angiogenesis. J. Oncol., 2012, 2012, 281261.
[http://dx.doi.org/10.1155/2012/281261] [PMID: 21876693]
[108]
Mulholland, D.J.; Dedhar, S.; Wu, H.; Nelson, C.C. PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer. Oncogene, 2006, 25(3), 329-337.
[http://dx.doi.org/10.1038/sj.onc.1209020] [PMID: 16421604]
[109]
Ruiz, P.A.; Braune, A.; Hölzlwimmer, G.; Quintanilla-Fend, L.; Haller, D. Quercetin inhibits TNF-induced NF-kappaB transcription factor recruitment to proinflammatory gene promoters in murine intestinal epithelial cells. J. Nutr., 2007, 137(5), 1208-1215.
[http://dx.doi.org/10.1093/jn/137.5.1208] [PMID: 17449583]
[110]
Pahl, H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene, 1999, 18(49), 6853-6866.
[http://dx.doi.org/10.1038/sj.onc.1203239] [PMID: 10602461]
[111]
Senthilkumar, K.; Elumalai, P.; Arunkumar, R.; Banudevi, S.; Gunadharini, N.D.; Sharmila, G.; Selvakumar, K.; Arunakaran, J. Quercetin regulates insulin like growth factor signaling and induces intrinsic and extrinsic pathway mediated apoptosis in androgen independent prostate cancer cells (PC-3). Mol. Cell. Biochem., 2010, 344(1-2), 173-184.
[http://dx.doi.org/10.1007/s11010-010-0540-4] [PMID: 20658310]
[112]
Asiedu, M.K.; Ingle, J.N.; Behrens, M.D.; Radisky, D.C.; Knutson, K.L. TGFbeta/TNF(α)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype. Cancer Res., 2011, 71(13), 4707-4719.
[http://dx.doi.org/10.1158/0008-5472.CAN-10-4554] [PMID: 21555371]
[113]
Huang, X.; Chen, S.; Xu, L.; Liu, Y.; Deb, D.K.; Platanias, L.C.; Bergan, R.C. Genistein inhibits p38 map kinase activation, matrix metalloproteinase type 2, and cell invasion in human prostate epithelial cells. Cancer Res., 2005, 65(8), 3470-3478.
[http://dx.doi.org/10.1158/0008-5472.CAN-04-2807] [PMID: 15833883]
[114]
Ahn, K.S.; Hahn, B.S.; Kwack, K.; Lee, E.B.; Kim, Y.S. Platycodin D-induced apoptosis through nuclear factor-kappaB activation in immortalized keratinocytes. Eur. J. Pharmacol., 2006, 537(1-3), 1-11.
[http://dx.doi.org/10.1016/j.ejphar.2006.03.012] [PMID: 16631160]
[115]
Chun, J.; Joo, E.J.; Kang, M.; Kim, Y.S. Platycodin D induces anoikis and caspase-mediated apoptosis via p38 MAPK in AGS human gastric cancer cells. J. Cell. Biochem., 2013, 114(2), 456-470.
[http://dx.doi.org/10.1002/jcb.24386] [PMID: 22961809]
[116]
Qin, H.; Du, X.; Zhang, Y.; Wang, R. Platycodin D, a triterpenoid saponin from Platycodon grandiflorum, induces G2/M arrest and apoptosis in human hepatoma HepG2 cells by modulating the PI3K/Akt pathway. Tumour Biol., 2014, 35(2), 1267-1274.
[http://dx.doi.org/10.1007/s13277-013-1169-1] [PMID: 24048756]
[117]
Li, T.; Tang, Z.H.; Xu, W.S.; Wu, G.S.; Wang, Y.F.; Chang, L.L.; Zhu, H.; Chen, X.P.; Wang, Y.T.; Chen, Y.; Lu, J.J. Platycodin D triggers autophagy through activation of extracellular signal-regulated kinase in hepatocellular carcinoma HepG2 cells. Eur. J. Pharmacol., 2015, 749, 81-88.
[http://dx.doi.org/10.1016/j.ejphar.2015.01.003] [PMID: 25592318]
[118]
Xia, D. Ovarian cancer HO-8910 cell apoptosis induced by crocin in vitro. Nat. Prod. Commun., 2015, 10(2), 249-252.
[http://dx.doi.org/10.1177/1934578X1501000208] [PMID: 25920253]
[119]
Lu, P.; Lin, H.; Gu, Y.; Li, L.; Guo, H.; Wang, F.; Qiu, X. Antitumor effects of crocin on human breast cancer cells. Int. J. Clin. Exp. Med., 2015, 8(11), 20316-20322.
[PMID: 26884946]
[120]
Samarghandian, S.; Shabestari, M.M. DNA fragmentation and apoptosis induced by safranal in human prostate cancer cell line. Indian J. Urol., 2013, 29(3), 177-183.
[http://dx.doi.org/10.4103/0970-1591.117278] [PMID: 24082436]
[121]
Virág, L.; Szabó, C. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol. Rev., 2002, 54(3), 375-429.
[http://dx.doi.org/10.1124/pr.54.3.375] [PMID: 12223530]
[122]
Enari, M.; Sakahira, H.; Yokoyama, H.; Okawa, K.; Iwamatsu, A.; Nagata, S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature, 1998, 391(6662), 43-50.
[http://dx.doi.org/10.1038/34112] [PMID: 9422506]
[123]
Freitas, R.D.S.; Campos, M.M. Protective effects of omega-3 fatty acids in cancer-related complications. Nutrients, 2019, 11(5), E945.
[http://dx.doi.org/10.3390/nu11050945] [PMID: 31035457]
[124]
Mandal, C.C. Osteolytic metastasis in breast cancer: effective prevention strategies. Expert Rev. Anticancer Ther., 2020, 20(9), 797-811.
[http://dx.doi.org/10.1080/14737140.2020.1807950] [PMID: 32772585]
[125]
Papaevangelou, E.; Almeida, G.S.; Box, C.; deSouza, N.M.; Chung, Y.L. The effect of FASN inhibition on the growth and metabolism of a cisplatin-resistant ovarian carcinoma model. Int. J. Cancer, 2018, 143(4), 992-1002.
[http://dx.doi.org/10.1002/ijc.31392] [PMID: 29569717]
[126]
Gazzerro, P.; Malfitano, A.M.; Proto, M.C.; Santoro, A.; Pisanti, S.; Caruso, M.G.; Notarnicola, M.; Messa, C.; Laezza, C.; Misso, G.; Caraglia, M.; Bifulco, M. Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin. Oncol. Rep., 2010, 23(1), 171-175.
[PMID: 19956878]
[127]
Sheng, H.; Chen, X.; Liu, B.; Li, P.; Cao, W. Omega-3 polyunsaturated fatty acids enhance cisplatin efficacy in gastric cancer cells by inducing apoptosis via ADORA1. Anticancer. Agents Med. Chem., 2016, 16(9), 1085-1092.
[http://dx.doi.org/10.2174/1871520616666160330104413] [PMID: 27025656]
[128]
Hong, Z.F.; Zhao, W.X.; Yin, Z.Y.; Xie, C.R.; Xu, Y.P.; Chi, X.Q.; Zhang, S.; Wang, X.M. Capsaicin enhances the drug sensitivity of cholangiocarcinoma through the inhibition of chemotherapeutic-induced autophagy. PLoS One, 2015, 10(5), e0121538.
[http://dx.doi.org/10.1371/journal.pone.0121538] [PMID: 25933112]
[129]
Calle, E.E.; Kaaks, R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer, 2004, 4(8), 579-591.
[http://dx.doi.org/10.1038/nrc1408] [PMID: 15286738]
[130]
Ryder, J.R.; Kaizer, A.; Rudser, K.D.; Gross, A.; Kelly, A.S.; Fox, C.K. Effect of phentermine on weight reduction in a pediatric weight management clinic. Int. J. Obesity (2005)., 2017, 41(1), 90-93.
[http://dx.doi.org/10.1038/ijo.2016.185]
[131]
Montan, P.D.; Sourlas, A.; Olivero, J.; Silverio, D.; Guzman, E.; Kosmas, C.E. Pharmacologic therapy of obesity: mechanisms of action and cardiometabolic effects. Ann. Transl. Med., 2019, 7(16), 393.
[http://dx.doi.org/10.21037/atm.2019.07.27] [PMID: 31555707]
[132]
Collins, G.T.; Gerak, L.R.; France, C.P. The behavioral pharmacology and therapeutic potential of lorcaserin for substance use disorders. Neuropharmacology, 2018, 142, 63-71.
[http://dx.doi.org/10.1016/j.neuropharm.2017.12.023] [PMID: 29246856]
[133]
Mancini, M.C.; Halpern, A. Orlistat in the prevention of diabetes in the obese patient. Vasc. Health Risk Manag., 2008, 4(2), 325-336.
[http://dx.doi.org/10.2147/VHRM.S6808] [PMID: 18561508]
[134]
Overgaard, R.V.; Petri, K.C.; Jacobsen, L.V.; Jensen, C.B. Liraglutide 3.0 mg for weight management: a population pharmacokinetic analysis. Clin. Pharmacokinet., 2016, 55(11), 1413-1422.
[http://dx.doi.org/10.1007/s40262-016-0410-7] [PMID: 27193270]
[135]
Jacobsen, L.V.; Flint, A.; Olsen, A.K.; Ingwersen, S.H. Liraglutide in type 2 diabetes mellitus: Clinical pharmacokinetics and pharmacodynamics. Clin. Pharmacokinet., 2016, 55(6), 657-672.
[http://dx.doi.org/10.1007/s40262-015-0343-6] [PMID: 26597252]
[136]
Lee, A.; Morley, J.E. Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes. Obes. Res., 1998, 6(1), 47-53.
[http://dx.doi.org/10.1002/j.1550-8528.1998.tb00314.x] [PMID: 9526970]
[137]
Levri, K.M.; Slaymaker, E.; Last, A.; Yeh, J.; Ference, J.; D’Amico, F.; Wilson, S.A. Metformin as treatment for overweight and obese adults: a systematic review. Ann. Fam. Med., 2005, 3(5), 457-461.
[http://dx.doi.org/10.1370/afm.343] [PMID: 16189063]
[138]
Valencia, W.M.; Palacio, A.; Tamariz, L.; Florez, H. Metformin and ageing: improving ageing outcomes beyond glycaemic control. Diabetologia, 2017, 60(9), 1630-1638.
[http://dx.doi.org/10.1007/s00125-017-4349-5] [PMID: 28770328]
[139]
Jenkins, A.J.; Welsh, P.; Petrie, J.R. Metformin, lipids and atherosclerosis prevention. Curr. Opin. Lipidol., 2018, 29(4), 346-353.
[http://dx.doi.org/10.1097/MOL.0000000000000532] [PMID: 29878903]
[140]
Smith, S.M.; Meyer, M.; Trinkley, K.E. Phentermine/topiramate for the treatment of obesity. Ann. Pharmacother., 2013, 47(3), 340-349.
[http://dx.doi.org/10.1345/aph.1R501] [PMID: 23482732]
[141]
Joo, J.K.; Lee, K.S. Pharmacotherapy for obesity. J. Menopausal Med., 2014, 20(3), 90-96.
[http://dx.doi.org/10.6118/jmm.2014.20.3.90] [PMID: 25580419]
[142]
Chatzis, P.; Tziomalos, K.; Pratilas, G.C.; Makris, V.; Sotiriadis, A.; Dinas, K. The role of antiobesity agents in the management of polycystic ovary syndrome. Folia Med. (Plovdiv), 2018, 60(4), 512-520.
[http://dx.doi.org/10.2478/folmed-2018-0036] [PMID: 31188761]
[143]
Hendricks, E.J. Off-label drugs for weight management. Diabetes Metab. Syndr. Obes., 2017, 10, 223-234.
[http://dx.doi.org/10.2147/DMSO.S95299] [PMID: 28652791]
[144]
Mehrpouya-Bahrami, P.; Chitrala, K.N.; Ganewatta, M.S.; Tang, C.; Murphy, E.A.; Enos, R.T.; Velazquez, K.T.; McCellan, J.; Nagarkatti, M.; Nagarkatti, P. Blockade of CB1 cannabinoid receptor alters gut microbiota and attenuates inflammation and diet-induced obesity. Sci. Rep., 2017, 7(1), 15645.
[http://dx.doi.org/10.1038/s41598-017-15154-6] [PMID: 29142285]
[145]
Sharma, A.M. Sibutramine in overweight/obese hypertensive patients. Int. J. Obesity Related Metabolic Disord., 2001, 25(Suppl 4), S20-S23.
[146]
Holst, J.J.; Albrechtsen, N.J.W.; Gabe, M.B.N.; Rosenkilde, M.M. Oxyntomodulin: Actions and role in diabetes. Peptides, 2018, 100, 48-53.
[http://dx.doi.org/10.1016/j.peptides.2017.09.018] [PMID: 29412831]
[147]
Mack, C.M.; Soares, C.J.; Wilson, J.K.; Athanacio, J.R.; Turek, V.F.; Trevaskis, J.L. Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight. Int. J. Obesity., 2010, 34(2), 385-395.
[148]
Rascol, O.; Poewe, W.; Lees, A.; Aristin, M.; Salin, L.; Juhel, N.; Waldhauser, L.; Schindler, T. ADVANS Study Group. Tesofensine (NS 2330), a monoamine reuptake inhibitor, in patients with advanced Parkinson disease and motor fluctuations: the ADVANS Study. Arch. Neurol., 2008, 65(5), 577-583.
[http://dx.doi.org/10.1001/archneur.65.5.577] [PMID: 18474731]
[149]
Kennett, G.A.; Clifton, P.G. New approaches to the pharmacological treatment of obesity: can they break through the efficacy barrier? Pharmacol. Biochem. Behav., 2010, 97(1), 63-83.
[http://dx.doi.org/10.1016/j.pbb.2010.07.020] [PMID: 20688100]
[150]
Nagao, K.; Jinnouchi, T.; Kai, S.; Yanagita, T. Pterostilbene, a dimethylated analog of resveratrol, promotes energy metabolism in obese rats. J. Nutr. Biochem., 2017, 43, 151-155.
[http://dx.doi.org/10.1016/j.jnutbio.2017.02.009] [PMID: 28319852]
[151]
McCormack, D.; McFadden, D. A review of pterostilbene antioxidant activity and disease modification. Oxid. Med. Cell. Longev., 2013, 2013, 575482.
[http://dx.doi.org/10.1155/2013/575482] [PMID: 23691264]
[152]
Chang, H.C.; Lewis, D.; Tung, C.Y.; Han, L.; Henriquez, S.M.; Voiles, L.; Lupov, I.P.; Pelloso, D.; Sinn, A.L.; Pollok, K.E.; de Lumen, B.O.; Li, F.; Blum, J.S.; Srivastava, S.; Robertson, M.J. Soypeptide lunasin in cytokine immunotherapy for lymphoma. Cancer Immunol. Immunother., 2014, 63(3), 283-295.
[http://dx.doi.org/10.1007/s00262-013-1513-8] [PMID: 24363024]
[153]
Bachala, D.; El-Refai, N.; Greenfield, E.; Aminoshariae, A.; Mickel, A. The effect of lunasin on receptor activator of nuclear factor Kappa-B ligand-mediated osteoclast formation from RAW 264.7 cells. J. Endod., 2018, 44(6), 997-999.
[http://dx.doi.org/10.1016/j.joen.2018.02.023] [PMID: 29680727]
[154]
Nguyen, H.N.; Ahn, Y.J.; Medina, E.A.; Asmis, R. Dietary 23-hydroxy ursolic acid protects against atherosclerosis and obesity by preventing dyslipidemia-induced monocyte priming and dysfunction. Atherosclerosis, 2018, 275, 333-341.
[http://dx.doi.org/10.1016/j.atherosclerosis.2018.06.882] [PMID: 30015296]
[155]
Springer, M.; Moco, S. Resveratrol and its human metabolites-effects on metabolic health and obesity. Nutrients, 2019, 11(1), E143.
[http://dx.doi.org/10.3390/nu11010143] [PMID: 30641865]
[156]
Hou, C.Y.; Tain, Y.L.; Yu, H.R.; Huang, L.T. The Effects of resveratrol in the treatment of metabolic syndrome. Int. J. Mol. Sci., 2019, 20(3), E535.
[http://dx.doi.org/10.3390/ijms20030535] [PMID: 30695995]
[157]
Kumar, A.; Rimando, A.M.; Levenson, A.S. Resveratrol and pterostilbene as a microRNA-mediated chemopreventive and therapeutic strategy in prostate cancer. Ann. N. Y. Acad. Sci., 2017, 1403(1), 15-26.
[http://dx.doi.org/10.1111/nyas.13372] [PMID: 28662290]
[158]
Le, N.H.; Kim, C.S.; Park, T.; Park, J.H.; Sung, M.K.; Lee, D.G.; Hong, S.M.; Choe, S.Y.; Goto, T.; Kawada, T.; Yu, R. Quercetin protects against obesity-induced skeletal muscle inflammation and atrophy. Mediators Inflamm., 2014, 2014, 834294.
[http://dx.doi.org/10.1155/2014/834294] [PMID: 25614714]
[159]
Mielczarek-Puta, M; Chrzanowska, A; Otto-Ślusarczyk, D; Graboń, W; Barańczyk-Kuźma, A. [Effect of antioxidants on human primary and metastatic colon cancer cells at hypoxia and normoxia]. Wiadomosci lekarskie (Warsaw, Poland : 1960)., 2017, 70(5), 946-952..
[160]
Poudel, B.; Lim, S.W.; Ki, H.H.; Nepali, S.; Lee, Y.M.; Kim, D.K. Dioscin inhibits adipogenesis through the AMPK/MAPK pathway in 3T3-L1 cells and modulates fat accumulation in obese mice. Int. J. Mol. Med., 2014, 34(5), 1401-1408.
[http://dx.doi.org/10.3892/ijmm.2014.1921] [PMID: 25189808]
[161]
Li, C.; Lu, Y.; Du, S.; Li, S.; Zhang, Y.; Liu, F.; Chen, Y.; Weng, D.; Chen, J. Dioscin exerts protective effects against crystalline silica-induced pulmonary fibrosis in mice. Theranostics, 2017, 7(17), 4255-4275.
[http://dx.doi.org/10.7150/thno.20270] [PMID: 29158824]
[162]
Li, S.; Cheng, B.; Hou, L.; Huang, L.; Cui, Y.; Xu, D.; Shen, X.; Li, S. Dioscin inhibits colon cancer cells’ growth by reactive oxygen species-mediated mitochondrial dysfunction and p38 and JNK pathways. Anticancer Drugs, 2018, 29(3), 234-242.
[http://dx.doi.org/10.1097/CAD.0000000000000590] [PMID: 29389802]
[163]
Lin, Y.C.; Lin, Y.C.; Kuo, W.W.; Shen, C.Y.; Cheng, Y.C.; Lin, Y.M.; Chang, R.L.; Padma, V.V.; Huang, C.Y.; Huang, C.Y. Platycodin D reverses pathological cardiac hypertrophy and fibrosis in spontaneously hypertensive rats. Am. J. Chin. Med., 2018, 46(3), 537-549.
[http://dx.doi.org/10.1142/S0192415X18500271] [PMID: 29595072]
[164]
Zeng, C.C.; Zhang, C.; Yao, J.H.; Lai, S.H.; Han, B.J.; Li, W.; Tang, B.; Wan, D.; Liu, Y.J. Platycodin D induced apoptosis and autophagy in PC-12 cells through mitochondrial dysfunction pathway. Spectrochim. Acta A Mol. Biomol. Spectrosc., 2016, 168, 199-205.
[http://dx.doi.org/10.1016/j.saa.2016.06.005] [PMID: 27294548]
[165]
Gu, M.; Luo, L.; Fang, K. Crocin inhibits obesity via AMPK-dependent inhibition of adipocyte differentiation and promotion of lipolysis. Biosci. Trends, 2018, 12(6), 587-594.
[http://dx.doi.org/10.5582/bst.2018.01240] [PMID: 30674760]
[166]
Inoue, E.; Shimizu, Y.; Masui, R.; Hayakawa, T.; Tsubonoya, T.; Hori, S.; Sudoh, K. Effects of saffron and its constituents, crocin-1, crocin-2, and crocetin on α-synuclein fibrils. J. Nat. Med., 2018, 72(1), 274-279.
[http://dx.doi.org/10.1007/s11418-017-1150-1] [PMID: 29147836]
[167]
Lien, L.M.; Lin, K.H.; Huang, L.T.; Tseng, M.F.; Chiu, H.C.; Chen, R.J.; Lu, W.J. Licochalcone a prevents platelet activation and thrombus formation through the inhibition of PLCγ2-PKC, Akt, and MAPK Pathways. Int. J. Mol. Sci., 2017, 18(7), E1500.
[http://dx.doi.org/10.3390/ijms18071500] [PMID: 28704925]
[168]
Huang, W.C.; Su, H.H.; Fang, L.W.; Wu, S.J.; Liou, C.J.; Licochalcone, A. Inhibits cellular motility by suppressing E-cadherin and MAPK signaling in breast cancer. Cells, 2019, 8(3), E218.
[http://dx.doi.org/10.3390/cells8030218] [PMID: 30841634]
[169]
Pothuraju, R.; Sharma, R.K.; Chagalamarri, J.; Jangra, S.; Kumar Kavadi, P. A systematic review of Gymnema sylvestre in obesity and diabetes management. J. Sci. Food Agric., 2014, 94(5), 834-840.
[http://dx.doi.org/10.1002/jsfa.6458] [PMID: 24166097]
[170]
Stracquadanio, M.; Ciotta, L.; Palumbo, M.A. Effects of myo-inositol, gymnemic acid, and L-methylfolate in polycystic ovary syndrome patients. Gynecol. Endocrinol., 2018, 34(6), 495-501..
[171]
Zuñiga, L.Y.; González-Ortiz, M.; Martínez-Abundis, E. Effect of gymnema sylvestre administration on metabolic syndrome, insulin sensitivity, and insulin secretion. J. Med. Food, 2017, 20(8), 750-754.
[http://dx.doi.org/10.1089/jmf.2017.0001] [PMID: 28459647]
[172]
Xu, J.H.; Liu, X.Z.; Pan, W.; Zou, D.J. Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. Mol. Med. Rep., 2017, 15(5), 2765-2787.
[http://dx.doi.org/10.3892/mmr.2017.6321] [PMID: 28447763]
[173]
Xu, Z.; Feng, W.; Shen, Q.; Yu, N.; Yu, K.; Wang, S.; Chen, Z.; Shioda, S.; Guo, Y. Rhizoma coptidis and berberine as a natural drug to combat aging and aging-related diseases via anti-oxidation and AMPK activation. Aging Dis., 2017, 8(6), 760-777.
[http://dx.doi.org/10.14336/AD.2016.0620] [PMID: 29344415]
[174]
Wang, Y; Zhang, S Berberine suppresses growth and metastasis of endometrial cancer cells via miR-101/COX-2. Biomed pharmacother, 2018, 103, 1287-1293.
[175]
Zhao, Y.; Sedighi, R.; Wang, P.; Chen, H.; Zhu, Y.; Sang, S. Carnosic acid as a major bioactive component in rosemary extract ameliorates high-fat-diet-induced obesity and metabolic syndrome in mice. J. Agric. Food Chem., 2015, 63(19), 4843-4852.
[http://dx.doi.org/10.1021/acs.jafc.5b01246] [PMID: 25929334]
[176]
Ghasemzadeh Rahbardar, M; Amin, B.; Mehri, S.; Mirnajafi-Zadeh, S.J.; Hosseinzadeh, H. Anti-inflammatory effects of ethanolic extract of Rosmarinus officinalis L. and rosmarinic acid in a rat model of neuropathic pain. Biomed pharmacother, 2017, 86, 441-449.
[177]
Moore, J.; Yousef, M.; Tsiani, E. Anticancer effects of rosemary (Rosmarinus officinalis L.) extract and rosemary extract polyphenols. Nutrients, 2016, 8(11), E731.
[http://dx.doi.org/10.3390/nu8110731] [PMID: 27869665]
[178]
Baskaran, P.; Krishnan, V.; Ren, J.; Thyagarajan, B. Capsaicin induces browning of white adipose tissue and counters obesity by activating TRPV1 channel-dependent mechanisms. Br. J. Pharmacol., 2016, 173(15), 2369-2389.
[http://dx.doi.org/10.1111/bph.13514] [PMID: 27174467]
[179]
Basith, S.; Cui, M.; Hong, S.; Choi, S. Harnessing the therapeutic potential of capsaicin and its analogues in pain and other diseases. Molecules, 2016, 21(8), E966.
[http://dx.doi.org/10.3390/molecules21080966] [PMID: 27455231]
[180]
Dai, N.; Ye, R.; He, Q.; Guo, P.; Chen, H.; Zhang, Q. Capsaicin and sorafenib combination treatment exerts synergistic anti‑hepatocellular carcinoma activity by suppressing EGFR and PI3K/Akt/mTOR signaling. Oncol. Rep., 2018, 40(6), 3235-3248.
[PMID: 30272354]
[181]
Güler, S.; Zik, B. Effects of capsaicin on ovarian granulosa cell proliferation and apoptosis. Cell Tissue Res., 2018, 372(3), 603-609.
[http://dx.doi.org/10.1007/s00441-018-2803-4] [PMID: 29455258]
[182]
Saravanan, G.; Ponmurugan, P.; Deepa, M.A.; Senthilkumar, B. Anti-obesity action of gingerol: effect on lipid profile, insulin, leptin, amylase and lipase in male obese rats induced by a high-fat diet. J. Sci. Food Agric., 2014, 94(14), 2972-2977.
[http://dx.doi.org/10.1002/jsfa.6642] [PMID: 24615565]
[183]
Hwang, Y.H.; Kim, T.; Kim, R.; Ha, H. The natural product 6-gingerol inhibits inflammation-associated osteoclast differentiation via reduction of prostaglandin E2 levels. Int. J. Mol. Sci., 2018, 19(7), E2068.
[http://dx.doi.org/10.3390/ijms19072068] [PMID: 30013004]
[184]
Wang, C.; Shi, C.; Yang, X.; Yang, M.; Sun, H.; Wang, C. Celastrol suppresses obesity process via increasing antioxidant capacity and improving lipid metabolism. Eur. J. Pharmacol., 2014, 744, 52-58.
[http://dx.doi.org/10.1016/j.ejphar.2014.09.043] [PMID: 25300680]
[185]
Venkatesha, S.H.; Moudgil, K.D. Celastrol and its role in controlling chronic diseases. Adv. Exp. Med. Biol., 2016, 928, 267-289.
[http://dx.doi.org/10.1007/978-3-319-41334-1_12] [PMID: 27671821]
[186]
Behl, T.; Kotwani, A. Omega-3 fatty acids in prevention of diabetic retinopathy. J. Pharm. Pharmacol., 2017, 69(8), 946-954.
[http://dx.doi.org/10.1111/jphp.12744] [PMID: 28481011]
[187]
Tejada, S.; Martorell, M.; Capó, X.; Tur, J.A.; Pons, A.; Sureda, A. Omega-3 fatty acids in the management of epilepsy. Curr. Top. Med. Chem., 2016, 16(17), 1897-1905.
[http://dx.doi.org/10.2174/1568026616666160204123107] [PMID: 26845549]

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy
Request history8.2.27PHP Version323msRequest Duration28MBMemory UsageGET article/{article_id}/{param?}Route
  • warninglog[21:42:58] LOG.warning: Optional parameter $article_id declared before required parameter $request i...
  • warninglog[21:42:58] LOG.warning: Function strftime() is deprecated in /home/alphaeurekaselec/public_html/stor...
  • warninglog[21:42:58] LOG.warning: trim(): Passing null to parameter #1 ($string) of type string is deprecated ...
  • warninglog[21:42:58] LOG.warning: Function strftime() is deprecated in /home/alphaeurekaselec/public_html/stor...
  • Booting (105ms)time
  • Application (218ms)time
  • 1 x Application (67.54%)
    218ms
    1 x Booting (32.46%)
    105ms
    14 templates were rendered
    • articlearticle.blade.php#?blade
    • includes.article_top_bannerarticle_top_banner.blade.php#?blade
    • includes.article_referencearticle_reference.blade.php#?blade
    • export_citation_formexport_citation_form.blade.php#?blade
    • includes.article_bottom_bannerarticle_bottom_banner.blade.php#?blade
    • includes.inc_related_journalsinc_related_journals.blade.php#?blade
    • includes.inc_related_ebooksinc_related_ebooks.blade.php#?blade
    • includes.journal_rightmenujournal_rightmenu.blade.php#?blade
    • includes.journal_right_bannerjournal_right_banner.blade.php#?blade
    • layouts.appapp.blade.php#?blade
    • layouts._login_access_login_access.blade.php#?blade
    • layouts._header_header.blade.php#?blade
    • layouts._main_menu_main_menu.blade.php#?blade
    • layouts._footer_menu_footer_menu.blade.php#?blade
    uri
    GET article/{article_id}/{param?}
    middleware
    web, check_user_access
    controller
    App\Http\Controllers\ArticleController@GetArticleDetails
    namespace
    App\Http\Controllers
    where
    as
    article
    file
    app/Http/Controllers/ArticleController.php:1974-2510
    40 statements were executed, 4 of which were duplicates, 36 unique. Show only duplicated121ms
    • Connection Establishedalphaeurekaselec_live_10_06_2022UserAccessCheck.php#24
      Backtrace
      • 9. middleware::check_user_access:24
      • 10. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 11. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • INSERT INTO visitor_ip_address (ip_address,visitor_agent,visitor_count, created_on,updated_on) VALUES ('314516876','',1,1740346978,1740346978) ON DUPLICATE KEY UPDATE visitor_count=visitor_count + 1, updated_on=1740346978
      980μsalphaeurekaselec_live_10_06_2022UserAccessCheck.php#24
      Backtrace
      • 11. middleware::check_user_access:24
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 14. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 15. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • INSERT INTO visitor_ip_address_detail (ip_address,visitor_url,visitor_count, created_on,updated_on) VALUES ('314516876','/article/114991/cn',1,1740346978,1740346978)
      140μsalphaeurekaselec_live_10_06_2022UserAccessCheck.php#27
      Backtrace
      • 11. middleware::check_user_access:27
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 14. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 15. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_trail WHERE to_ip >= 314516876 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 314516876) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_corporate WHERE to_ip >= 314516876 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 314516876) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_token WHERE to_ip >= 314516876 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 314516876) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_trail WHERE to_ip >= 314516876 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 314516876) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_corporate WHERE to_ip >= 314516876 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 314516876) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_token WHERE to_ip >= 314516876 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 314516876) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_trail WHERE to_ip >= 314516876 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 314516876) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_corporate WHERE to_ip >= 314516876 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 314516876) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_token WHERE to_ip >= 314516876 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 314516876) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_trail WHERE to_ip >= 314516876 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 314516876) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_corporate WHERE to_ip >= 314516876 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 314516876) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_token WHERE to_ip >= 314516876 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 314516876) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_trail WHERE to_ip >= 314516876 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 314516876) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_corporate WHERE to_ip >= 314516876 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 314516876) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_token WHERE to_ip >= 314516876 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 314516876) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_disease_corporate WHERE to_ip >= 314516876 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 314516876) limit 1
      10.81msalphaeurekaselec_live_10_06_2022UserAccess.php#784
      Bindings
      • 0: 314516876
      • 1: 314516876
      • 2: 314516876
      • 3: 314516876
      • 4: 314516876
      • 5: 314516876
      • 6: 314516876
      • 7: 314516876
      • 8: 314516876
      • 9: 314516876
      • 10: 314516876
      • 11: 314516876
      • 12: 314516876
      • 13: 314516876
      • 14: 314516876
      • 15: 314516876
      Backtrace
      • 14. app/Models/UserAccess/UserAccess.php:784
      • 15. middleware::check_user_access:114
      • 16. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 18. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
    • SELECT at.type_name, p.copyright, p.publisher_location,m.month,y.year, a.publish_on, a.nid article_nid,a.article_id, a.pmid, a.issue_id, a.title, a.abstract,a.podcast,a.altmetric_score,a.altmetric_url,a.kudos_url, a.page_count, a.first_page, a.elocator, a.last_page, i.publication_date, a.file_name, a.file_path, a.doi, a.is_epub,a.epub_type, a.volume_id, a.is_uploaded, a.editor_choice, a.is_epub, j.image_file_name, a.article_no, a.art_type AS article_type, a.supplementary_filename,a.html_filename,a.prc_filename,a.epub_filename, a.graph_abs_lg_filename, a.graph_abs_sm_filename, a.oa_image_lg_filename, a.oa_image_sm_filename, j.journal_banner,a.animated_abstract,a.erratum_in,a.erratum_for, (CASE WHEN a.issue_id =0 THEN j.epub_price ELSE j.price END) AS sell_price, j.epub_price, j.nid AS jour_nid, j.title AS journal_title, j.issn, j.eissn,j.journal_id, j.subtitle AS jour_subtitle, v.volume_id,v.volume_name AS volume, v.year_id, i.title AS issue, i.month_id ,i.type issue_type, j.subtitle,j.formerly_title, ac.subtitle AS epub_title,a.crossmark_enabled,a.text_mining_urls,a.license_urls,a.created, a.receivedate, a.revisedate, a.acceptdate,js.js_title FROM article a LEFT JOIN article_section ac ON a.is_epub = ac.art_sec_id LEFT JOIN journal_section js ON a.js_id = js.js_id LEFT JOIN article_type at ON a.art_type = at.art_type_id LEFT JOIN issue i ON a.issue_id = i.issue_id LEFT JOIN month m ON m.id = i.month_id LEFT JOIN volume v ON v.volume_id = a.volume_id INNER JOIN year y ON y.id = v.year_id INNER JOIN journal j ON j.journal_id = a.journal_id INNER JOIN publisher p ON p.publisher_id = j.publisher_id WHERE a.article_id=114991
      970μsalphaeurekaselec_live_10_06_2022Article.php#408
      Backtrace
      • 11. app/Models/Article.php:408
      • 12. app/Http/Controllers/ArticleController.php:2515
      • 13. app/Http/Controllers/ArticleController.php:2035
      • 14. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 15. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `journal` where `journal_id` = 7 limit 1
      1.02msalphaeurekaselec_live_10_06_2022Journal.php#64
      Bindings
      • 0: 7
      Backtrace
      • 14. app/Models/Journal.php:64
      • 15. app/Http/Controllers/ArticleController.php:2516
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select count(*) as aggregate from (select j.nid as journal_nid,j.flyer_link,j.title ,j.issn,j.eissn,j.keyword, j.journal_id as journal_id, j.subtitle, j.image_file_name,j.description,j.journal_insight_url,j.doi from `subject_journal` as `sj` inner join `journal` as `j` on `j`.`journal_id` = `sj`.`journal_id` where j.journal_status=1 and subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=7) and sj.journal_id!=7 group by `j`.`nid`) as `aggregate_table`
      1.01msalphaeurekaselec_live_10_06_2022Subject.php#200
      Backtrace
      • 16. app/Models/Subject.php:200
      • 17. app/Http/Controllers/ArticleController.php:2517
      • 18. app/Http/Controllers/ArticleController.php:2035
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 20. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select j.nid as journal_nid,j.flyer_link,j.title ,j.issn,j.eissn,j.keyword, j.journal_id as journal_id, j.subtitle, j.image_file_name,j.description,j.journal_insight_url,j.doi from `subject_journal` as `sj` inner join `journal` as `j` on `j`.`journal_id` = `sj`.`journal_id` where j.journal_status=1 and subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=7) and sj.journal_id!=7 group by `j`.`nid` order by `j`.`journal_id` asc limit 10 offset 0
      800μsalphaeurekaselec_live_10_06_2022Subject.php#200
      Backtrace
      • 14. app/Models/Subject.php:200
      • 15. app/Http/Controllers/ArticleController.php:2517
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select count(*) as aggregate from (select v.nid as volume_id,e.nid,e.title,v.issn,v.eissn,v.isbn,v.eisbn,e.ebook_id, v.image_file_name,v.file_path,v.flyer_link,v.ebook_volume_id, v.volume_name,v.doi,v.year_id,v.introduction from `subject_ebook` as `se` inner join `ebook` as `e` on `e`.`ebook_id` = `se`.`ebook_id` inner join `ebook_volume` as `v` on `v`.`ebook_id` = `se`.`ebook_id` inner join `year` as `y` on `y`.`id` = `v`.`year_id` where subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=7) and v.ebook_status='1' and y.year > 2020 group by `v`.`nid`) as `aggregate_table`
      2.24msalphaeurekaselec_live_10_06_2022Subject.php#220
      Backtrace
      • 16. app/Models/Subject.php:220
      • 17. app/Http/Controllers/ArticleController.php:2518
      • 18. app/Http/Controllers/ArticleController.php:2035
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 20. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select v.nid as volume_id,e.nid,e.title,v.issn,v.eissn,v.isbn,v.eisbn,e.ebook_id, v.image_file_name,v.file_path,v.flyer_link,v.ebook_volume_id, v.volume_name,v.doi,v.year_id,v.introduction from `subject_ebook` as `se` inner join `ebook` as `e` on `e`.`ebook_id` = `se`.`ebook_id` inner join `ebook_volume` as `v` on `v`.`ebook_id` = `se`.`ebook_id` inner join `year` as `y` on `y`.`id` = `v`.`year_id` where subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=7) and v.ebook_status='1' and y.year > 2020 group by `v`.`nid` order by `v`.`ebook_volume_id` desc limit 10 offset 0
      1.94msalphaeurekaselec_live_10_06_2022Subject.php#220
      Backtrace
      • 14. app/Models/Subject.php:220
      • 15. app/Http/Controllers/ArticleController.php:2518
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `keywords` where `article_id` = '114991'
      1.72msalphaeurekaselec_live_10_06_2022Keywords.php#43
      Bindings
      • 0: 114991
      Backtrace
      • 13. app/Models/Keywords.php:43
      • 14. app/Http/Controllers/ArticleController.php:2519
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `article_citation` where `article_id` = '114991'
      5.04msalphaeurekaselec_live_10_06_2022Article.php#1570
      Bindings
      • 0: 114991
      Backtrace
      • 13. app/Models/Article.php:1570
      • 14. app/Http/Controllers/ArticleController.php:2520
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select CONCAT_WS(' ',au.first_name, ' ', ifnull(au.initials,''), ' ', au.last_name) as authors, CONCAT(au.last_name, IFNULL(CONCAT(' ', au.initials), ''), ' ', au.first_name) AS authorsRIS, CONCAT_WS(' ',au.last_name, ' ', ifnull(au.initials,''), ' ', au.first_name) as authorsCiteAs, CONCAT_WS(' ',au.first_name, IFNULL(CONCAT(' ', au.initials), ''), IFNULL(CONCAT(' ', au.last_name), '')) as authorsmodal , `au`.*, `af`.`ror_id`, `af`.`institution`, `af`.`department`, `af`.`country`, `af`.`city`, `af`.`address`, (GROUP_CONCAT(TRIM(BOTH ', ' FROM CONCAT(ifnull(concat(af.institution,','),''), ifnull(concat(af.department,','),''), ifnull(concat(af.address,','),''), ifnull(concat(af.city,','),''), ifnull(concat(af.country,','),''), ifnull(concat(af.postal_code,','),''), ifnull(concat(af.phone,','),''), ifnull(concat(af.fax,','),''))) SEPARATOR '|')) as `author_affiliation`, (GROUP_CONCAT(TRIM(BOTH ', ' FROM CONCAT(ifnull(concat(af.web_view,','),''))) SEPARATOR '|')) as `web_view` from `author` as `au` left join `author_affiliation` as `af` on `au`.`author_id` = `af`.`author_id` where `au`.`article_id` = '114991' group by `au`.`author_id` order by `au`.`article_id` asc, `au`.`sequence` asc
      1.84msalphaeurekaselec_live_10_06_2022Author.php#86
      Bindings
      • 0: 114991
      Backtrace
      • 13. app/Models/Author.php:86
      • 14. app/Http/Controllers/ArticleController.php:2533
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select `bo`.* from `bundle_offer` as `bo` where `bo`.`bundle_status` = 'A' order by `bo`.`bundle_id` desc
      260μsalphaeurekaselec_live_10_06_2022BundleOffer.php#57
      Bindings
      • 0: A
      Backtrace
      • 13. app/Models/BundleOffer.php:57
      • 14. app/Http/Controllers/ArticleController.php:2535
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select `subtitle` from `journal` where `continues_publication_journal` = 1
      640μsalphaeurekaselec_live_10_06_2022Article.php#1960
      Bindings
      • 0: 1
      Backtrace
      • 13. app/Models/Article.php:1960
      • 14. app/Http/Controllers/ArticleController.php:2062
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • Select j.subtitle, v.volume_id as volume_id,v.year_id,y.year as year,v.volume_name, v.total_no_of_issues, i.issue_id as issue_id,i.title as issue, i.publication_date as issue_pub_date from journal j join volume v on j.journal_id = v.journal_id join issue i on v.volume_id = i.volume_id join article a on a.issue_id = i.issue_id join year y on v.year_id = y.id where j.journal_id = 7 and i.is_uploaded = 1 order by v.volume_name+0 desc, i.title+0 desc limit 1
      35.98msalphaeurekaselec_live_10_06_2022Issue.php#298
      Backtrace
      • 11. app/Models/Issue.php:298
      • 12. app/Http/Controllers/ArticleController.php:2068
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select a.nid,a.publish_on, a.pmid,a.article_id,a.doi,j.journal_id,j.subtitle,v.volume_name,a.volume_id as volume_id, a.issue_id,a.title,first_page, last_page, page_count,abstract,ifnull(is_abstract,"y"),asec.title as article_section,at.type_name as article_type_name, a.article_id as ArticleID ,is_epub,epub_price,epub_type,a.created, y.year from `article` as `a` left join `article_section` as `asec` on `asec`.`art_sec_id` = `a`.`is_epub` left join `article_type` as `at` on `at`.`art_type_id` = `a`.`art_type` left join `journal` as `j` on `j`.`journal_id` = `a`.`journal_id` inner join `volume` as `v` on `a`.`volume_id` = `v`.`volume_id` inner join `year` as `y` on `v`.`year_id` = `y`.`id` where a.article_status != "W" and a.is_epub = 1 and a.journal_id = 7 and a.is_uploaded = 1 group by `a`.`article_id` order by `a`.`publish_on` desc
      14.15msalphaeurekaselec_live_10_06_2022Article.php#528
      Backtrace
      • 13. app/Models/Article.php:528
      • 14. app/Http/Controllers/ArticleController.php:2070
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select a.nid,a.publish_on, a.pmid,a.article_id,a.doi,j.journal_id,j.subtitle,v.volume_name,a.volume_id as volume_id, a.issue_id,a.title,first_page, last_page, page_count,abstract,ifnull(is_abstract,"y"),asec.title as article_section,at.type_name as article_type_name, a.article_id as ArticleID ,is_epub,epub_price,epub_type,a.created, y.year from `article` as `a` left join `article_section` as `asec` on `asec`.`art_sec_id` = `a`.`is_epub` left join `article_type` as `at` on `at`.`art_type_id` = `a`.`art_type` left join `journal` as `j` on `j`.`journal_id` = `a`.`journal_id` inner join `volume` as `v` on `a`.`volume_id` = `v`.`volume_id` inner join `year` as `y` on `v`.`year_id` = `y`.`id` where a.article_status != "W" and a.is_epub = 4 and a.journal_id = 7 and a.is_uploaded = 1 group by `a`.`article_id` order by `a`.`publish_on` desc
      11.73msalphaeurekaselec_live_10_06_2022Article.php#528
      Backtrace
      • 13. app/Models/Article.php:528
      • 14. app/Http/Controllers/ArticleController.php:2071
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select pdf, html, epub, prc from `article_metrics` where `article_id` = 114991 limit 1
      250μsalphaeurekaselec_live_10_06_2022Article.php#744
      Bindings
      • 0: 114991
      Backtrace
      • 14. app/Models/Article.php:744
      • 15. app/Http/Controllers/ArticleController.php:2091
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from content_by_diseases where content_id = 114991 and content_type = 'article' order by status desc limit 1
      270μsalphaeurekaselec_live_10_06_2022Article.php#751
      Backtrace
      • 11. app/Models/Article.php:751
      • 12. app/Http/Controllers/ArticleController.php:2094
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `node_meta` where `nid` = 192392 limit 1
      200μsalphaeurekaselec_live_10_06_2022Meta.php#30
      Bindings
      • 0: 192392
      Backtrace
      • 14. app/Models/Meta.php:30
      • 15. app/Http/Controllers/ArticleController.php:2101
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `bo`.* from `bundle_offer` as `bo` where `bo`.`bundle_status` = 'A' order by `bo`.`bundle_id` desc
      210μsalphaeurekaselec_live_10_06_2022BundleOffer.php#57
      Bindings
      • 0: A
      Backtrace
      • 13. app/Models/BundleOffer.php:57
      • 14. app/Http/Controllers/ArticleController.php:2108
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `tbl_ht_submission` as `h` where `h`.`subtitle` = 'CCDT' and (h.proposal_closing_date = 0 OR TO_DAYS(FROM_UNIXTIME(h.proposal_closing_date)) >= TO_DAYS(NOW())) order by `h`.`manuscript` asc
      290μsalphaeurekaselec_live_10_06_2022Article.php#2025
      Bindings
      • 0: CCDT
      Backtrace
      • 13. app/Models/Article.php:2025
      • 14. app/Http/Controllers/ArticleController.php:2112
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select count(*) as total_count, content_type_access_id as access_type from journal_access where content_type_id = '114991' and content_type = 'a' and ( (from_date <= CURDATE() and to_date >= CURDATE() and perpetual= 0) or (from_date is null and to_date is null and perpetual= 1) )
      340μsalphaeurekaselec_live_10_06_2022ContentAccess.php#647
      Backtrace
      • 11. app/Models/ContentAccess.php:647
      • 12. app/Http/Controllers/ArticleController.php:2186
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select count(*) as total_count, content_type_access_id as access_type from journal_access where content_type_id = '10838' and content_type = 'i' and ( (from_date <= CURDATE() and to_date >= CURDATE() and perpetual= 0) or (from_date is null and to_date is null and perpetual= 1) )
      300μsalphaeurekaselec_live_10_06_2022ContentAccess.php#647
      Backtrace
      • 11. app/Models/ContentAccess.php:647
      • 12. app/Http/Controllers/ArticleController.php:2207
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select count(*) as total_count, content_type_access_id as access_type from journal_access where content_type_id = '2970' and content_type = 'v' and ( (from_date <= CURDATE() and to_date >= CURDATE() and perpetual= 0) or (from_date is null and to_date is null and perpetual= 1) )
      260μsalphaeurekaselec_live_10_06_2022ContentAccess.php#647
      Backtrace
      • 11. app/Models/ContentAccess.php:647
      • 12. app/Http/Controllers/ArticleController.php:2231
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Trial Access" as access_base_text, CASE j.type WHEN 111 THEN true ELSE false END as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"volume" as access_level,"" as issue_id,"" as article_id from `user_access_journal_volume_trail` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 314516876 and j.to_ip >=314516876 )) and ((j.from_date <= 1740346978 and j.to_date >= 1740346978 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.volume_id = 2970) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Subscribed" as access_base_text, false as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"volume" as access_level,"" as issue_id,"" as article_id from `user_access_journal_volume_corporate` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 314516876 and j.to_ip >=314516876 )) and ((j.from_date <= 1740346978 and j.to_date >= 1740346978 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.volume_id = 2970) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Token Based Access" as access_base_text, false as terms_popup, "R" as content_download_type, j.uc_id as restricted_user_access_key, "v" as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"volume" as access_level,"" as issue_id,"" as article_id from `user_access_journal_volume_token` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 314516876 and j.to_ip >=314516876 )) and ((j.from_date <= 1740346978 and j.to_date >= 1740346978 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.volume_id = 2970)
      8.47msalphaeurekaselec_live_10_06_2022UserAccess.php#1266
      Backtrace
      • 13. app/Models/UserAccess/UserAccess.php:1266
      • 14. app/Http/Controllers/ArticleController.php:2272
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Trial Access" as access_base_text, CASE j.type WHEN 111 THEN true ELSE false END as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"issue" as access_level,j.issue_id,"" as article_id from `user_access_issue_trail` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 314516876 and j.to_ip >=314516876 )) and ((j.from_date <= 1740346978 and j.to_date >= 1740346978 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.issue_id = 10838) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Subscribed" as access_base_text, false as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"issue" as access_level,j.issue_id,"" as article_id from `user_access_issue_corporate` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 314516876 and j.to_ip >=314516876 )) and ((j.from_date <= 1740346978 and j.to_date >= 1740346978 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.issue_id = 10838) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Token Based Access" as access_base_text, false as terms_popup, "R" as content_download_type, j.uc_id as restricted_user_access_key, "v" as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"issue" as access_level,j.issue_id,"" as article_id from `user_access_issue_token` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 314516876 and j.to_ip >=314516876 )) and ((j.from_date <= 1740346978 and j.to_date >= 1740346978 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.issue_id = 10838)
      610μsalphaeurekaselec_live_10_06_2022UserAccess.php#1266
      Backtrace
      • 13. app/Models/UserAccess/UserAccess.php:1266
      • 14. app/Http/Controllers/ArticleController.php:2297
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Trial Access" as access_base_text, CASE j.type WHEN 111 THEN true ELSE false END as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"article" as access_level, j.issue_id, j.article_id from `user_access_article_trail` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 314516876 and j.to_ip >=314516876 )) and ((j.from_date <= 1740346978 and j.to_date >= 1740346978 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.article_id = 114991) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Subscribed" as access_base_text, false as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"article" as access_level, j.issue_id, j.article_id from `user_access_article_corporate` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 314516876 and j.to_ip >=314516876 )) and ((j.from_date <= 1740346978 and j.to_date >= 1740346978 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.article_id = 114991) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Token Based Access" as access_base_text, false as terms_popup, "R" as content_download_type, j.uc_id as restricted_user_access_key, "v" as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"article" as access_level, j.issue_id, j.article_id from `user_access_article_token` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 314516876 and j.to_ip >=314516876 )) and ((j.from_date <= 1740346978 and j.to_date >= 1740346978 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.article_id = 114991)
      610μsalphaeurekaselec_live_10_06_2022UserAccess.php#1266
      Backtrace
      • 13. app/Models/UserAccess/UserAccess.php:1266
      • 14. app/Http/Controllers/ArticleController.php:2329
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `article` where `first_page` < '476' and is_uploaded = 1 and issue_id = 10838 order by cast(first_page as SIGNED) desc limit 1
      460μsalphaeurekaselec_live_10_06_2022Article.php#1819
      Bindings
      • 0: 476
      Backtrace
      • 14. app/Models/Article.php:1819
      • 15. app/Http/Controllers/ArticleController.php:2470
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `article` where `last_page` > '494' and is_uploaded = 1 and issue_id = 10838 order by cast(first_page as SIGNED) asc limit 1
      440μsalphaeurekaselec_live_10_06_2022Article.php#1831
      Bindings
      • 0: 494
      Backtrace
      • 14. app/Models/Article.php:1831
      • 15. app/Http/Controllers/ArticleController.php:2472
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `language_id` from `multilanguage` where `short_code` = 'cn'
      180μsalphaeurekaselec_live_10_06_2022ArticleController.php#2486
      Bindings
      • 0: cn
      Backtrace
      • 14. app/Http/Controllers/ArticleController.php:2486
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:206
    • select `source_lang_label`, `target_lang_label` from `multilanguage_labels` where `target_lang_id` = 2
      200μsalphaeurekaselec_live_10_06_2022MultiLanguage.php#23
      Bindings
      • 0: 2
      Backtrace
      • 13. app/Models/MultiLanguage.php:23
      • 14. app/Http/Controllers/ArticleController.php:2487
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `multilanguage_article` where (`language_id` = 2 and `article_id` = 114991)
      5.7msalphaeurekaselec_live_10_06_2022ArticleController.php#2488
      Bindings
      • 0: 2
      • 1: 114991
      Backtrace
      • 15. app/Http/Controllers/ArticleController.php:2488
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Route.php:206
    • select `keyword` from `multilanguage_keywords` where (`language_id` = 2 and `article_id` = 114991)
      2.48msalphaeurekaselec_live_10_06_2022ArticleController.php#2489
      Bindings
      • 0: 2
      • 1: 114991
      Backtrace
      • 14. app/Http/Controllers/ArticleController.php:2489
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:206
    • select CONCAT_WS(' ',au.first_name, ' ', ifnull(au.initials,''), ' ', au.last_name) as authors, CONCAT_WS(' ',au.last_name, ', ', ifnull(au.initials,''), ' ', au.first_name) as authorsRIS, CONCAT_WS(' ',au.last_name, ' ', ifnull(au.initials,''), ' ', au.first_name) as authorsCiteAs , `au`.*, (GROUP_CONCAT(TRIM(BOTH ', ' FROM CONCAT(ifnull(concat(af.institution,','),''), ifnull(concat(af.department,','),''), ifnull(concat(af.address,','),''), ifnull(concat(af.city,','),''), ifnull(concat(af.country,','),''), ifnull(concat(af.postal_code,','),''), ifnull(concat(af.phone,','),''), ifnull(concat(af.fax,','),''))) SEPARATOR '|')) as `author_affiliation`, (GROUP_CONCAT(TRIM(BOTH ', ' FROM CONCAT(ifnull(concat(af.web_view,','),''))) SEPARATOR '|')) as `web_view` from `multilanguage_authors` as `au` left join `multilanguage_author_affiliation` as `af` on `au`.`id` = `af`.`author_id` where `au`.`article_id` = 114991 group by `au`.`id` order by `au`.`article_id` asc, `au`.`sequence` asc
      3.85msalphaeurekaselec_live_10_06_2022MultiLangAuthor.php#30
      Bindings
      • 0: 114991
      Backtrace
      • 13. app/Models/MultiLangAuthor.php:30
      • 14. app/Http/Controllers/ArticleController.php:2493
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `multilanguage_journal`.`title` from `multilanguage_journal` where `multilanguage_journal`.`journal_id` = 7 and `language_id` = 2
      220μsalphaeurekaselec_live_10_06_2022ArticleController.php#2495
      Bindings
      • 0: 7
      • 1: 2
      Backtrace
      • 13. app/Http/Controllers/ArticleController.php:2495
      • 14. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 15. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:206
    • select `id` from `multilanguage_article` where `article_id` = 114991 limit 1
      2.08msalphaeurekaselec_live_10_06_2022ArticleController.php#2506
      Bindings
      • 0: 114991
      Backtrace
      • 16. app/Http/Controllers/ArticleController.php:2506
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
      • 20. vendor/laravel/framework/src/Illuminate/Routing/Route.php:206
    • select b.banner_link, b.banner_name, b.banner_script, b.banner_remarks, b.banner_file_name, b.banner_placement, bd.content_type, bd.content_id from `tbl_banner` as `b` inner join `tbl_banner_detail` as `bd` on `bd`.`banner_id` = `b`.`banner_id` inner join `users` as `u` on `u`.`id` = `b`.`updated_by` inner join `journal` as `j` on `j`.`journal_id` = `bd`.`content_id` where `b`.`banner_journal` = 1 and `bd`.`content_type` = 'J' and `bd`.`content_id` = 7 and `b`.`banner_from_date` <= 1740346978 and `b`.`banner_to_date` >= 1740346978 and `b`.`banner_status` = 'A' order by `b`.`banner_id` desc
      1.18msalphaeurekaselec_live_10_06_2022Banner.php#95
      Bindings
      • 0: 1
      • 1: J
      • 2: 7
      • 3: 1740346978
      • 4: 1740346978
      • 5: A
      Backtrace
      • 13. app/Models/Banner.php:95
      • 14. app/Http/helpers.php:404
      • 17. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 18. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    • select b.banner_link, b.banner_name, b.banner_script, b.banner_remarks, b.banner_file_name, b.banner_placement, bd.content_type, bd.content_id from `tbl_banner` as `b` inner join `tbl_banner_detail` as `bd` on `bd`.`banner_id` = `b`.`banner_id` inner join `users` as `u` on `u`.`id` = `b`.`updated_by` inner join `journal` as `j` on `j`.`journal_id` = `bd`.`content_id` where `b`.`banner_journal` = 1 and `bd`.`content_type` = 'J' and `bd`.`content_id` = 7 and `b`.`banner_from_date` <= 1740346978 and `b`.`banner_to_date` >= 1740346978 and `b`.`banner_status` = 'A' order by `b`.`banner_id` desc
      1.2msalphaeurekaselec_live_10_06_2022Banner.php#95
      Bindings
      • 0: 1
      • 1: J
      • 2: 7
      • 3: 1740346978
      • 4: 1740346978
      • 5: A
      Backtrace
      • 13. app/Models/Banner.php:95
      • 14. app/Http/helpers.php:404
      • 17. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 18. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    • select count(*) as aggregate from `uc_cart_products` where cart_id='c0b33cca08558aa08c39fe4add264d2f'
      210μsalphaeurekaselec_live_10_06_2022Cart.php#271
      Backtrace
      • 15. app/Models/Cart.php:271
      • 16. view::layouts._header:260
      • 18. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 20. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    App\Models\MultiLangArticle
    2MultiLangArticle.php#?
    App\Models\MultiLanguage
    1MultiLanguage.php#?
        _token
        7oOLN0RqvUCh2zDS0h5wgEtdTziFXgoa6bb5fCch
        uc_cart_id
        c0b33cca08558aa08c39fe4add264d2f
        _previous
        array:1 [ "url" => "http://alpha.eurekaselect.com/article/114991/cn" ]
        _flash
        array:2 [ "old" => [] "new" => [] ]
        PHPDEBUGBAR_STACK_DATA
        []
        path_info
        /article/114991/cn
        status_code
        200
        
        status_text
        OK
        format
        html
        content_type
        text/html; charset=UTF-8
        request_query
        []
        
        request_request
        []
        
        request_headers
        0 of 0
        array:9 [ "cookie" => array:1 [ 0 => "wayfindertarget=eyJpdiI6IkxSbjFjVkU4WnRKSS9XdVhQU094anc9PSIsInZhbHVlIjoiMjA2dnA5TWJjc1Q1WTFWNUdrb0VLUXluRUZqZG56MmdIWUpvNXAyQk53Zz0iLCJtYWMiOiJjMWI4NzRlY2JjMzlmYzc1NDA2NzY3YzkxNjBiYTUyODRiNDgyZTk5NmIxODY5NTc1NjJiYTg5ZjI0NTBkNjAxIiwidGFnIjoiIn0%3Dwayfindertarget=eyJpdiI6IkxSbjFjVkU4WnRKSS9XdVhQU094anc9PSIsInZhbHVlIjoiMjA2dnA5TWJjc1Q1WTFWNUdrb0VLUXluRUZqZG56MmdIWUpvNXAyQk53Zz0iLCJtYWMiOiJjMWI4NzRlY2JjMzlm" ] "accept-encoding" => array:1 [ 0 => "gzip, deflate" ] "accept" => array:1 [ 0 => "text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.7" ] "user-agent" => array:1 [ 0 => "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)" ] "upgrade-insecure-requests" => array:1 [ 0 => "1" ] "cache-control" => array:1 [ 0 => "no-cache" ] "pragma" => array:1 [ 0 => "no-cache" ] "connection" => array:1 [ 0 => "keep-alive" ] "host" => array:1 [ 0 => "alpha.eurekaselect.com" ] ]
        request_cookies
        0 of 0
        array:1 [ "wayfindertarget" => null ]
        response_headers
        0 of 0
        array:5 [ "content-type" => array:1 [ 0 => "text/html; charset=UTF-8" ] "cache-control" => array:1 [ 0 => "no-cache, private" ] "date" => array:1 [ 0 => "Sun, 23 Feb 2025 21:42:58 GMT" ] "set-cookie" => array:2 [ 0 => "XSRF-TOKEN=eyJpdiI6ImJ4ZkdwNWQ1VEwwdTNnM0RNSDlBWEE9PSIsInZhbHVlIjoiZkl4Nm5FUjlWRXFYTmhKMUxRTkF5UWNSS0M1dWY0VHJ1SUE0RUhkVVR2UXB0VXZ6RitXVGh6T3NRQktrMHl4YWJRU2FxcXN2bHJwbzU4SyttWWNSK1Jjb3dyZ05LOWVyL0F1RjQxMEdWekVDUDRNRzhmZUVwN2hmc1BGZWJSUFMiLCJtYWMiOiI4MWY0ZTNiNjg2MjJjODliZWQzYzQ0MGIxMzg3YTdkYzdhODlhOWFlZjMwODQxYTZiMWFmMzZkNWVlOWMxZmNmIiwidGFnIjoiIn0%3D; expires=Wed, 26 Feb 2025 09:42:58 GMT; Max-Age=216000; path=/; secure; samesite=laxXSRF-TOKEN=eyJpdiI6ImJ4ZkdwNWQ1VEwwdTNnM0RNSDlBWEE9PSIsInZhbHVlIjoiZkl4Nm5FUjlWRXFYTmhKMUxRTkF5UWNSS0M1dWY0VHJ1SUE0RUhkVVR2UXB0VXZ6RitXVGh6T3NRQktrMHl4YWJRU2Fxc" 1 => "alphaeurekaselectnet_session=eyJpdiI6IjB0R2NPQVFSNEZ3UWNwUzdTS0g1Unc9PSIsInZhbHVlIjoiWk02NWZJYnlmelY5OVA1RjVDZUYzdmZVeUJHK1JvNmVXa3N6Nkc0dVpia2U2bisxYkdGeldvd3Y5ZWJXbWxtNzNOR2FLa2FwNlRhR2hEcTZ6QVlINmdBaERFbDlyUUswTGo1K1dKbVJkSDNHcTl1c0RkaXZpcG1ab3FHWDROTFUiLCJtYWMiOiJjM2MyZDBkMzUxZmQwZTdiZDY2YzVlY2VhMjNhZTkwMjE5ZjViY2Q1Zjg1YTY3NDY1OTgzMDhmNDQxY2QwMDA2IiwidGFnIjoiIn0%3D; path=/; secure; httponly; samesite=laxalphaeurekaselectnet_session=eyJpdiI6IjB0R2NPQVFSNEZ3UWNwUzdTS0g1Unc9PSIsInZhbHVlIjoiWk02NWZJYnlmelY5OVA1RjVDZUYzdmZVeUJHK1JvNmVXa3N6Nkc0dVpia2U2bisxYkdGeldvd3Y" ] "Set-Cookie" => array:2 [ 0 => "XSRF-TOKEN=eyJpdiI6ImJ4ZkdwNWQ1VEwwdTNnM0RNSDlBWEE9PSIsInZhbHVlIjoiZkl4Nm5FUjlWRXFYTmhKMUxRTkF5UWNSS0M1dWY0VHJ1SUE0RUhkVVR2UXB0VXZ6RitXVGh6T3NRQktrMHl4YWJRU2FxcXN2bHJwbzU4SyttWWNSK1Jjb3dyZ05LOWVyL0F1RjQxMEdWekVDUDRNRzhmZUVwN2hmc1BGZWJSUFMiLCJtYWMiOiI4MWY0ZTNiNjg2MjJjODliZWQzYzQ0MGIxMzg3YTdkYzdhODlhOWFlZjMwODQxYTZiMWFmMzZkNWVlOWMxZmNmIiwidGFnIjoiIn0%3D; expires=Wed, 26-Feb-2025 09:42:58 GMT; path=/; secureXSRF-TOKEN=eyJpdiI6ImJ4ZkdwNWQ1VEwwdTNnM0RNSDlBWEE9PSIsInZhbHVlIjoiZkl4Nm5FUjlWRXFYTmhKMUxRTkF5UWNSS0M1dWY0VHJ1SUE0RUhkVVR2UXB0VXZ6RitXVGh6T3NRQktrMHl4YWJRU2Fxc" 1 => "alphaeurekaselectnet_session=eyJpdiI6IjB0R2NPQVFSNEZ3UWNwUzdTS0g1Unc9PSIsInZhbHVlIjoiWk02NWZJYnlmelY5OVA1RjVDZUYzdmZVeUJHK1JvNmVXa3N6Nkc0dVpia2U2bisxYkdGeldvd3Y5ZWJXbWxtNzNOR2FLa2FwNlRhR2hEcTZ6QVlINmdBaERFbDlyUUswTGo1K1dKbVJkSDNHcTl1c0RkaXZpcG1ab3FHWDROTFUiLCJtYWMiOiJjM2MyZDBkMzUxZmQwZTdiZDY2YzVlY2VhMjNhZTkwMjE5ZjViY2Q1Zjg1YTY3NDY1OTgzMDhmNDQxY2QwMDA2IiwidGFnIjoiIn0%3D; path=/; secure; httponlyalphaeurekaselectnet_session=eyJpdiI6IjB0R2NPQVFSNEZ3UWNwUzdTS0g1Unc9PSIsInZhbHVlIjoiWk02NWZJYnlmelY5OVA1RjVDZUYzdmZVeUJHK1JvNmVXa3N6Nkc0dVpia2U2bisxYkdGeldvd3Y" ] ]
        session_attributes
        0 of 0
        array:5 [ "_token" => "7oOLN0RqvUCh2zDS0h5wgEtdTziFXgoa6bb5fCch" "uc_cart_id" => "c0b33cca08558aa08c39fe4add264d2f" "_previous" => array:1 [ "url" => "http://alpha.eurekaselect.com/article/114991/cn" ] "_flash" => array:2 [ "old" => [] "new" => [] ] "PHPDEBUGBAR_STACK_DATA" => [] ]
        ClearShow all
        Date ↕MethodURLData
        #12025-02-23 21:42:58GET/article/114991/cn414403